Advanced diagnostic testing in Interstitial Lung Disease (ILD)


00:00:03.040 --> 00:00:06.800
Alright,
welcome everyone and welcome to this talk.

00:00:06.800 --> 00:00:10.853
So we're going to be talking about an advanced diagnostic testing today and

00:00:10.853 --> 00:00:12.240
trustitional lung disease.

00:00:12.920 --> 00:00:14.240
My name is Stacy Lok.

00:00:14.760 --> 00:00:19.240
I'll be your moderator tonight and it's my pleasure to introduce our speaker.

00:00:19.960 --> 00:00:24.323
I am an assistant professor at the University of Saskatchewan and also a

00:00:24.323 --> 00:00:25.400
specialist in ILD.

00:00:26.280 --> 00:00:30.945
My colleague here, Doctor Jolene Fisher, is a research director at the University

00:00:30.945 --> 00:00:33.961
of - Sorry,
a director of interstitial lung disease

00:00:33.961 --> 00:00:38.228
program at the University Health Network and an assistant professor at the

00:00:38.228 --> 00:00:39.479
University of Toronto.

00:00:39.840 --> 00:00:43.929
She's received her Doctor of Medicine and Internal Medicine residency training

00:00:43.929 --> 00:00:46.000
program from the University of Manitoba.

00:00:46.360 --> 00:00:49.874
She then completed a respirology residency and interstitial lung disease

00:00:49.874 --> 00:00:53.584
fellowship and a Masters of Science in clinical Epidemiology and Healthcare

00:00:53.584 --> 00:00:55.440
research at the University of Toronto.

00:00:56.040 --> 00:00:59.892
Her research interests include interstitial lung disease, health service

00:00:59.892 --> 00:01:02.280
research,
registries and outcomes research.

00:01:03.440 --> 00:01:06.879
So tonight,
we hope that you find value in tonight's

00:01:06.879 --> 00:01:09.800
unaccredited medical education presentation.

00:01:10.440 --> 00:01:14.766
Before we start,
we want to cover a few housekeeping items

00:01:14.766 --> 00:01:16.160
for the next slide.

00:01:16.160 --> 00:01:18.875
Here,
we ask that you provide us with feedback

00:01:18.875 --> 00:01:22.920
at the conclusion of the event by completing the sessions evaluation.

00:01:23.560 --> 00:01:27.858
We'll be posting the evaluation link in the chat box at the end of tonight's
b2007389-845f-468c-aa26-b192ae6c933a-1 

00:01:27.858 --> 00:01:31.040
presentation prior to the Q and A portion of this event.
3fe7ce4d-fb25-4221-8800-19a9c3d99589-0

00:01:31.040 --> 00:01:35.085
We truly appreciate you taking the time to provide feedback because it helps us
3fe7ce4d-fb25-4221-8800-19a9c3d99589-1

00:01:35.085 --> 00:01:38.777
shape future programs and ensure that we're developing medical education
3fe7ce4d-fb25-4221-8800-19a9c3d99589-2

00:01:38.777 --> 00:01:42.974
programs that provide value. To ensure the best possible sound quality for everyone
3fe7ce4d-fb25-4221-8800-19a9c3d99589-3

00:01:42.974 --> 00:01:43.480
attending.
03a4349b-ec5d-49e8-bab8-1174df5fe25f-0 

00:01:43.480 --> 00:01:46.882
We note that all participant lines will remain unmuted or sorry,
03a4349b-ec5d-49e8-bab8-1174df5fe25f-1 

00:01:46.882 --> 00:01:48.400
muted throughout the program.
b6864a8a-3e09-4061-af3b-a2faa618c3af-0 

00:01:49.040 --> 00:01:52.280
If you have any questions,
please type into the chat box at any time.
93d688c8-1c34-4169-b9f6-811a8e3aaa36-0

00:01:53.160 --> 00:01:57.241
This presentation is being recorded and
will be made available with slides after
93d688c8-1c34-4169-b9f6-811a8e3aaa36-1

00:01:57.241 --> 00:01:58.400
this evening's program.
41e6f96c-eefb-4d75-8886-24c3b4504a20-0

00:02:00.280 --> 00:02:04.270
It is also important to note that this program has received financial support
41e6f96c-eefb-4d75-8886-24c3b4504a20-1

00:02:04.270 --> 00:02:05.600
from Boehringer Ingelheim.
37d8a18a-cc59-4e7a-961c-bd6b66868023-0

00:02:05.760 --> 00:02:09.360
The faculty has received an honorarium for their participation.
aaa922dc-0a0c-42b0-8413-96d391bf1529-0 

00:02:11.600 --> 00:02:15.392
In the spirit of balance and integrity, there are sorry,
aaa922dc-0a0c-42b0-8413-96d391bf1529-1 

00:02:15.392 --> 00:02:20.054
this evening's program is fair and balanced and the faculty has been fully
aaa922dc-0a0c-42b0-8413-96d391bf1529-2 

00:02:20.054 --> 00:02:25.090
responsible for developing all content of this learning activity and the spirit,
aaa922dc-0a0c-42b0-8413-96d391bf1529-3 

00:02:25.090 --> 00:02:27.080
spirit of balance and integrity.
1b2da3ee-c231-4099-995c-338ce4c51099-0

00:02:27.080 --> 00:02:32.960
There's a few of the faculty's disclosures attached on the next slide.
f6c1b1fd-09eb-4e34-8dd7-d8f9da6268fb-0 

00:02:34.920 --> 00:02:39.080
And now it's my pleasure to pass things over to Doctor Jolene Fisher.
4d10601a-19b9-46cc-8ec6-27970833c66b-0

00:02:39.080 --> 00:02:42.520
Thank you.
dbf1ebf3-86b8-4dc4-b877-f47b123a4ca1-0

00:02:43.120 --> 00:02:47.960
Always nice to see a fellow Prairie person.
4bf7ecd7-9a2e-4b65-b6b7-cf0491dcd1d4-0 

00:02:49.480 --> 00:02:54.721
I'm really excited to be talking about an
update in advance diagnostic testing in
4bf7ecd7-9a2e-4b65-b6b7-cf0491dcd1d4-1 

00:02:54.721 --> 00:02:59.569
ILD this evening and the objectives of the session today are to develop a
4bf7ecd7-9a2e-4b65-b6b7-cf0491dcd1d4-2 

00:02:59.569 --> 00:03:04.744
guideline based and practical approach to the use of what I consider currently
4bf7ecd7-9a2e-4b65-b6b7-cf0491dcd1d4-3 

00:03:04.744 --> 00:03:09.854
available ILD diagnostics including bronchoscopy with bronchoalveolar lavage,
4bf7ecd7-9a2e-4b65-b6b7-cf0491dcd1d4-4 

00:03:09.854 --> 00:03:13.720
surgical lung biopsy and trans bronchial lung cryobiopsy.
de24a01f-af99-450d-a3c4-71dc612e48b8-0 

00:03:16.240 --> 00:03:21.065
I want to spend a little bit of time talking about what I consider newish or
de24a01f-af99-450d-a3c4-71dc612e48b8-1 

00:03:21.065 --> 00:03:26.142
maybe not widely available diagnostics such as the genomic classifier as well as
de24a01f-af99-450d-a3c4-71dc612e48b8-2 

00:03:26.142 --> 00:03:27.960
telomere and genetic testing.
1d147959-5908-46a8-86e5-e3c80048c707-0

00:03:30.920 --> 00:03:34.739
And then lastly,
take a look at some of the emerging and
1d147959-5908-46a8-86e5-e3c80048c707-1

00:03:34.739 --> 00:03:36.280
future ILD diagnostics.
0ebe4074-0d59-44cb-879a-177255e13d47-0

00:03:36.280 --> 00:03:40.139
There's quite a bit,
it's I think a really exciting and
0ebe4074-0d59-44cb-879a-177255e13d47-1

00:03:40.139 --> 00:03:43.999
evolving active area,
but I want to spend a bit of time
0ebe4074-0d59-44cb-879a-177255e13d47-2

00:03:43.999 --> 00:03:49.512
focusing specifically on endobronchial optical coherence tomography or EBOCT as
0ebe4074-0d59-44cb-879a-177255e13d47-3

00:03:49.512 --> 00:03:50.959
well as a few others.
72c7017f-066f-4f43-91ec-0b4dc40a6b14-0

00:03:55.160 --> 00:03:56.560
All right, so let's start with the case.
24081b42-1d86-4a5f-aadf-ed1690a0390f-0 

00:03:56.560 --> 00:04:00.615
So this is a 70 year old man who presented to clinic with a several month
24081b42-1d86-4a5f-aadf-ed1690a0390f-1 

00:04:00.615 --> 00:04:03.520
history of cough and exertional shortness of breath.
28f2d758-29c8-4f08-93e7-e7573b8e544e-0

00:04:04.680 --> 00:04:10.520
Really had no relevant past medical history, so never smoker, no medications.
bef38a8d-c218-4ee0-90c8-e0bd733ca2a4-0 

00:04:11.440 --> 00:04:15.167
Extensive review of systems for connective tissue disease symptoms was
bef38a8d-c218-4ee0-90c8-e0bd733ca2a4-1 

00:04:15.167 --> 00:04:15.640
negative.
af19de95-0b9a-43dc-b426-e2feff4d6539-0 

00:04:16.360 --> 00:04:19.720
No organic or inorganic exposures could be identified.
db20c8d3-eaab-4715-a6a4-ae6d42f37ded-0 

00:04:19.760 --> 00:04:23.327
Had no family history of connective tissue disease or ILD,
db20c8d3-eaab-4715-a6a4-ae6d42f37ded-1 

00:04:23.327 --> 00:04:27.680
and extensive serologic testing for an autoimmune disease was negative.
63d3b1f4-28ba-498b-808b-114dc54a80da-0 

00:04:31.600 --> 00:04:33.400
And so this was the CT scan.
15fc2cba-77e1-40a9-ae65-c2bc02c2091a-0 

00:04:33.400 --> 00:04:38.701
So just a screenshot of an axial image and you can see here hopefully that there
15fc2cba-77e1-40a9-ae65-c2bc02c2091a-1 

00:04:38.701 --> 00:04:42.040
is some ground glass opacity that's quite diffuse.
dbcb3b63-ec63-4eab-8ea8-ded6eaaf719a-0 

00:04:43.520 --> 00:04:45.040
There is some mosaic attenuation.
80fa6e76-d98d-445c-8ac0-779a3712e944-0

00:04:45.040 --> 00:04:49.120
So there's areas of whiter lung next to areas of darker lung.
786dbb84-4384-4660-99cd-cb1a0e96bb6b-0 

00:04:49.520 --> 00:04:52.680
And there is what we would consider the three density signs.
35f8d1b6-30df-4686-8cc4-428597cbc5ab-0 

00:04:52.680 --> 00:04:56.763
So there's areas of black lung, what would be in keeping with air
35f8d1b6-30df-4686-8cc4-428597cbc5ab-1 

00:04:56.763 --> 00:04:57.320
trapping.
d4a8fc40-7576-4a14-acab-0e2a41050100-0 

00:04:57.360 --> 00:05:01.480
There's areas of increased density and keeping with ground glass opacity.
e752342d-9d75-40ef-ac3d-339c2d01ba35-0 

00:05:01.480 --> 00:05:03.520
And then there's some areas of normal lung.
a9743ab9-294e-41ef-aa07-73d6b62bc938-0

00:05:06.880 --> 00:05:09.127
I'm not showing the expiratory images here,
a9743ab9-294e-41ef-aa07-73d6b62bc938-1 

00:05:09.127 --> 00:05:11.120
but there was evidence of gas trapping.
8794748e-ef5d-43ed-8625-36eefbabc966-0 

00:05:11.360 --> 00:05:12.960
There's no clear fibrosis.
759333a4-d4e4-4f46-b594-a942e2704618-0

00:05:13.280 --> 00:05:17.200
And if you were to scroll through all the images, which you're not going to do,
09e3b997-da07-470b-892a-082fa9e79270-0

00:05:17.200 --> 00:05:21.433
So I'm just going to tell you it was quite a diffuse pattern with no real
09e3b997-da07-470b-892a-082fa9e79270-1

00:05:21.433 --> 00:05:22.520
zonal predominance.
6a2613f8-8436-4a48-a88b-a042429b87b5-0

00:05:27.240 --> 00:05:29.520
All right,
so I have a polling question for you.
d261b52b-242d-4d1e-8a58-3390a40dc91f-0 

00:05:29.800 --> 00:05:31.200
What would you do next?
2358fcb7-6382-4f95-97f4-6718db37263d-0

00:05:31.640 --> 00:05:37.004
A dart steroids B perform bronchoscopy for microbiology,
2358fcb7-6382-4f95-97f4-6718db37263d-1

00:05:37.004 --> 00:05:39.640
cell count and differential.
27b987c6-58e2-4910-a0cb-b9ff38c6f63b-0 

00:05:40.800 --> 00:05:47.400
C cryobiopsy or D surgical lung biopsy.
54d807ad-4e13-4ab8-b927-8a11f153a726-0

00:05:50.320 --> 00:05:55.280
Just give everyone a little bit of time to vote.
20cc5878-b65c-4148-a9a8-8353303deb54-0

00:05:55.280 --> 00:06:01.800
Votes are still coming in.
79750c6e-686e-4b0b-ad2a-98aaa6c03996-0 

00:06:02.400 --> 00:06:04.200
Feel like we need some music for this part.
a34fffbe-0724-4e0e-8f32-1b9569af8178-0 

00:06:16.400 --> 00:06:20.240
Votes are still coming in,
so maybe I'll give it another 10 seconds.
2862c757-94cf-4be5-b97b-4ff15909631d-0

00:06:27.940 --> 00:06:34.974
All right,
Why don't we end it there and show the
2862c757-94cf-4be5-b97b-4ff15909631d-1

00:06:34.974 --> 00:06:36.100
results?
2f1bba61-7d2b-4553-866a-806b541176bf-0

00:06:37.860 --> 00:06:44.201
So these results should be showing up for you and hopefully you can see that about
2f1bba61-7d2b-4553-866a-806b541176bf-1

00:06:44.201 --> 00:06:49.778
3/4 of the participants suggested bronchoscopy with BAL for microbiology
2f1bba61-7d2b-4553-866a-806b541176bf-2

00:06:49.778 --> 00:06:55.279
cell counting differential and then a quarter suggested just forget it.
592b6ff2-efb1-47dd-8632-e789f8b56ad1-0 

00:06:56.560 --> 00:06:58.600
I'm pragmatic, let's start the steroids.
269a8fa3-17ab-4396-9ec3-8d65a635d264-0

00:06:59.240 --> 00:07:02.520
And then nobody suggested cryobiopsy or surgical lung biopsy.
bbf9d3c1-f8f8-481a-b92f-27d095ba4a55-0 

00:07:04.880 --> 00:07:09.160
All right,
So when do we consider advanced
bbf9d3c1-f8f8-481a-b92f-27d095ba4a55-1 

00:07:09.160 --> 00:07:13.640
diagnostic testing in our patients with
ILD?
b5b0dc88-a9f6-4f9b-a523-0b96511919ae-0 

00:07:14.480 --> 00:07:19.840
This figure is from the more recent ATS-IPF diagnostic guidelines.
4b87888a-8300-4374-b66b-0ea3942377dd-0

00:07:19.840 --> 00:07:22.206
And I think most of you probably will recognize it,
4b87888a-8300-4374-b66b-0ea3942377dd-1

00:07:22.206 --> 00:07:25.120
but I want to spend just a little bit of time going through it.
d3a33662-7394-43aa-8341-2e7e2932a51c-0 

00:07:25.480 --> 00:07:30.672
So when we're thinking about a patient that might have IPF, as you know,
d3a33662-7394-43aa-8341-2e7e2932a51c-1 

00:07:30.672 --> 00:07:36.505
we do you know an extensive work up for a potential cause or associated condition
d3a33662-7394-43aa-8341-2e7e2932a51c-2 

00:07:36.505 --> 00:07:40.560
such as extensive exposure history, autoimmune serology.
854c0266-8638-4833-8bde-5e536c7573d5-0

00:07:41.160 --> 00:07:44.798
Obviously if we find a diagnosis an underlying condition,
854c0266-8638-4833-8bde-5e536c7573d5-1

00:07:44.798 --> 00:07:46.680
then it's not going to be IPF.
8f4801b0-8425-454b-bb79-3a7667c971b1-0

00:07:46.680 --> 00:07:51.411
If we don't find anything,
we're spending a lot of time looking at
8f4801b0-8425-454b-bb79-3a7667c971b1-1

00:07:51.411 --> 00:07:56.496
that CT pattern and trying to characterize it into a UIP, probable UIP,
8f4801b0-8425-454b-bb79-3a7667c971b1-2

00:07:56.496 --> 00:08:01.440
indeterminate for UIP or most in keeping
with an alternate diagnosis.
78f65efd-be82-4f19-afbc-e0e4f5b2d186-0 

00:08:02.200 --> 00:08:05.440
And if available,
we're discussing these cases at an MDD.
74779cd7-852e-44c7-beca-639408d5f151-0

00:08:05.680 --> 00:08:10.298
And if it is indeterminate for UIP or in keeping with an alternate diagnosis,
74779cd7-852e-44c7-beca-639408d5f151-1

00:08:10.298 --> 00:08:15.154
those are really the patients that we're thinking about doing advanced diagnostic
74779cd7-852e-44c7-beca-639408d5f151-2

00:08:15.154 --> 00:08:18.174
testing,
whether it is just BAL with cell counted
74779cd7-852e-44c7-beca-639408d5f151-3

00:08:18.174 --> 00:08:22.320
differential, transbronchial lung cryobiopsy or surgical lung biopsy.
52703926-7d08-4a0a-9378-a526eb35fcbc-0

00:08:26.000 --> 00:08:31.666
And this panel here shows a figure from the hypersensitivity pneumonitis
52703926-7d08-4a0a-9378-a526eb35fcbc-1

00:08:31.666 --> 00:08:32.520
guidelines.
a6f4a061-f629-4cc7-ae1d-426cf503c43e-0 

00:08:32.520 --> 00:08:37.337
So if we're looking at it from an HP lens, so we have a patient with newly detected
a6f4a061-f629-4cc7-ae1d-426cf503c43e-1 

00:08:37.337 --> 00:08:42.040
interstitial lung abnormalities on a CT chest and we're thinking could this be HP?
2eed7103-2bf4-493a-98f4-abaf65c8dabe-0 

00:08:42.600 --> 00:08:46.080
We're doing that extensive exposure, exposure assessment.
93b3e1cd-feeb-4704-b7a7-dda710b5b7c4-0 

00:08:46.440 --> 00:08:52.658
We're looking at that CT scan and really
they recommend BAL with lymphocyte
93b3e1cd-feeb-4704-b7a7-dda710b5b7c4-1 

00:08:52.658 --> 00:08:58.714
cellular analysis plus or minus a transbronchial biopsy earlier on in the
93b3e1cd-feeb-4704-b7a7-dda710b5b7c4-2 

00:08:58.714 --> 00:09:00.760
the diagnostic algorithm.
e101506d-0e8d-4708-aae8-6761507b71bf-0 

00:09:02.640 --> 00:09:06.746
And then if you,
if you do have someone that has a typical
e101506d-0e8d-4708-aae8-6761507b71bf-1 

00:09:06.746 --> 00:09:10.087
CT pattern,
typical exposure and lymphocytosis,
e101506d-0e8d-4708-aae8-6761507b71bf-2 

00:09:10.087 --> 00:09:14.960
often you can make a high diagnosis, high confidence diagnosis of HP.
b45e8b4d-179e-4985-a170-992be0bda67e-0 

00:09:15.440 --> 00:09:19.037
But if after all that,
the diagnosis is still unclear, you know,
b45e8b4d-179e-4985-a170-992be0bda67e-1 

00:09:19.037 --> 00:09:23.077
that's when you're really looking at transbronchial lung cryobiopsy or
b45e8b4d-179e-4985-a170-992be0bda67e-2 

00:09:23.077 --> 00:09:24.240
surgical lung biopsy.
6e1f9f2d-ae17-4397-8a30-8f9a80f2501d-0

00:09:28.760 --> 00:09:31.160
All right, so when to consider BAL?
f603f0ef-4708-4235-93c1-463feee6c0cb-0 

00:09:31.160 --> 00:09:36.405
So really you should be thinking about BAL when you want to rule out infection,
f603f0ef-4708-4235-93c1-463feee6c0cb-1 

00:09:36.405 --> 00:09:39.880
when you want to obtain cell count and
differentials.
7fa341b9-a10b-4228-8471-becefd589801-0

00:09:39.880 --> 00:09:44.901
So looking for lymphocytosis is helpful for distinguishing hypersensitivity
7fa341b9-a10b-4228-8471-becefd589801-1

00:09:44.901 --> 00:09:47.280
pneumonitis from IPF or sarcoidosis.
d3054d33-c40e-49ec-b1f8-7e5f8e68e12b-0 

00:09:47.280 --> 00:09:50.880
In certain cases,
a high eosinophil count can suggest
d3054d33-c40e-49ec-b1f8-7e5f8e68e12b-1 

00:09:50.880 --> 00:09:53.280
eosinophilic pneumonia, for example.
a9873308-b41b-4296-adfa-2ac8caab6702-0 

00:09:54.760 --> 00:10:01.453
And when you look specifically at trying to distinguish fibrotic HP from IPF, BAL
a9873308-b41b-4296-adfa-2ac8caab6702-1 

00:10:01.453 --> 00:10:05.218
fluid,
lymphocyte thresholds of 20%, 30% and
40%
a9873308-b41b-4296-adfa-2ac8caab6702-2 

00:10:05.218 --> 00:10:09.736
will have sensitivities of 69%, 55% and 41%respectively,
a9873308-b41b-4296-adfa-2ac8caab6702-3 

00:10:09.736 --> 00:10:13.000
and then specificities of 61%, 80% and 93%.
c74533db-94fe-414a-9542-23ae433c5577-0 

00:10:13.000 --> 00:10:16.256
So, you know,
obviously the higher the lymphocyte
c74533db-94fe-414a-9542-23ae433c5577-1 

00:10:16.256 --> 00:10:20.880
thresholds, the better the specificity, but the worse the sensitivity.
ebd55cfc-e5a2-4de5-abf2-2aeb70d76eba-0 

00:10:26.560 --> 00:10:29.600
So what do the guidelines say that you should do?
2e62b610-a784-47f1-88b7-f7e99c8055c0-0

00:10:30.880 --> 00:10:35.829
The HP guidelines say that for patients with newly identified ILD where the
2e62b610-a784-47f1-88b7-f7e99c8055c0-1

00:10:35.829 --> 00:10:39.020
differential diagnosis includes non fibrotic HP,
2e62b610-a784-47f1-88b7-f7e99c8055c0-2

00:10:39.020 --> 00:10:43.840
the guideline committee recommends BAL with lymphocyte cellular analysis.
e692961b-4156-4e2a-8c3b-f9775164ae6e-0 

00:10:44.240 --> 00:10:49.064
And then for patients where the differential diagnosis includes fibrotic
e692961b-4156-4e2a-8c3b-f9775164ae6e-1 

00:10:49.064 --> 00:10:51.443
HP,
the guidelines suggest BAL with
e692961b-4156-4e2a-8c3b-f9775164ae6e-2 

00:10:51.443 --> 00:10:53.359
lymphocyte cellular analysis.
3fe0f766-1b4e-4ae1-82dd-ad34f4547ac4-0 

00:10:53.360 --> 00:10:59.643
So just to remind you,
recommending basically means that in most
3fe0f766-1b4e-4ae1-82dd-ad34f4547ac4-1 

00:10:59.643 --> 00:11:02.640
cases you would probably do it.
98d94969-8f98-4221-b7a4-4e8dcc4b750a-0

00:11:02.680 --> 00:11:06.716
Suggesting means that you know, it's, if somebody didn't do it,
98d94969-8f98-4221-b7a4-4e8dcc4b750a-1

00:11:06.716 --> 00:11:09.240
you wouldn't think that they were crazy.
3705e49a-a31b-4570-9a68-e797c8695634-0

00:11:12.400 --> 00:11:17.960
And then for IPF,
the guidelines suggested performing BAL
bbfae4f9-b4e0-4b28-95b4-45fd5641622e-0 

00:11:17.960 --> 00:11:21.880
This was a conditional suggestion, so pretty soft for patients with
bbfae4f9-b4e0-4b28-95b4-45fd5641622e-1 

00:11:21.880 --> 00:11:26.376
indeterminate and alternative and then probable with with an* which basically
bbfae4f9-b4e0-4b28-95b4-45fd5641622e-2 

00:11:26.376 --> 00:11:29.720
means many of them you know, it's probably not necessary.
6f1d7c1b-43bd-401a-bf05-7142d65d566f-0 

00:11:30.200 --> 00:11:33.833
And then in patients who have a UIP-CT pattern,
6f1d7c1b-43bd-401a-bf05-7142d65d566f-1 

00:11:33.833 --> 00:11:37.080
the recommendation was not to perform BAL.
f8c31c0b-bafe-45e5-a4f7-300422510385-0 

00:11:40.840 --> 00:11:44.120
So what do I do really?
3960f8f9-5c64-40b0-bfdd-73eb7855958c-0

00:11:44.120 --> 00:11:46.880
I perform BAL if infection is possible.
e991fb2f-0ee7-4b7a-919e-cff880204d60-0 

00:11:46.880 --> 00:11:49.640
So that really would include most non fibrotic HP.
bcf56dad-d581-4e4b-a21e-c00aed745f89-0 

00:11:49.640 --> 00:11:56.004
So I also would have done a BAL in this patient who ended up having non fibrotic
bcf56dad-d581-4e4b-a21e-c00aed745f89-1 

00:11:56.004 --> 00:11:56.240
HP.
5ef4192d-5e00-4305-8947-24113c8a68e2-0

00:11:57.840 --> 00:12:03.275
And then I would consider it in patients with an indeterminant or alternative for
5ef4192d-5e00-4305-8947-24113c8a68e2-1

00:12:03.275 --> 00:12:07.120
UIP-CT pattern if there's really no other clear diagnosis.
af393a26-d578-419c-94d6-11195aa00f75-0 

00:12:07.120 --> 00:12:09.560
And I think it has the potential to change, change my management.
9301cfb8-0106-4374-8297-06e4cb03f5a5-0

00:12:09.560 --> 00:12:12.480
So I'm definitely a pragmatist.
7143d990-2e2d-481c-91af-999f53a431e9-0

00:12:12.480 --> 00:12:14.800
I always think,
is this going to change management?
56b247bc-433b-47e1-bc3c-7ccc51905fc4-0 

00:12:16.080 --> 00:12:21.265
And then if I'm thinking about fibrotic HP, I do consider BAL, but I don't,
56b247bc-433b-47e1-bc3c-7ccc51905fc4-1 

00:12:21.265 --> 00:12:26.240
I wouldn't end up doing it universally on all my fibrotic HP patients.
fd712468-dee9-4df5-9e36-256c24bfc1e3-0 

00:12:26.240 --> 00:12:28.680
Although if you do do that,

I certainly think it's reasonable.
703daa0e-3e8b-4d73-9d82-7a0fbca47180-0 

00:12:30.040 --> 00:12:31.160
Again, you know it.
79dfdede-e56b-48f4-9e22-9c99e5699d47-0 

00:12:31.440 --> 00:12:35.007
It depends on whether or not I what else I think might be in the differential,
79dfdede-e56b-48f4-9e22-9c99e5699d47-1 

00:12:35.007 --> 00:12:38.440
and whether or not the result is really going to help me change management.
7aa2216f-2b46-4254-94b1-fc3de269dbd5-0 

00:12:45.080 --> 00:12:49.160
All right, so let's move on to case 2.5ca0a29d-54aa-4cb2-89ce-2ba7522c9168-0 

00:12:49.320 --> 00:12:54.597
So the reason for this patient's referral was whether or not she should have a
5ca0a29d-54aa-4cb2-89ce-2ba7522c9168-1 

00:12:54.597 --> 00:12:56.000
surgical lung biopsy. 
0bff4d63-9522-41ca-8427-8e83c2e94fc1-0

00:12:56.000 --> 00:13:00.901
And so this was a 55 year old female who presented with two years of shortness of
0bff4d63-9522-41ca-8427-8e83c2e94fc1-1

00:13:00.901 --> 00:13:01.320
breath.
4c3fc749-bb90-4e00-b0ec-3282a46cd471-0 

00:13:01.600 --> 00:13:05.840
She also had really no significant exposures.
63dae806-e808-4d9f-8d41-68db76356426-0

00:13:05.840 --> 00:13:09.760
She had no family history,
nothing up for connective tissue disease.
10d29c7f-969a-483c-955f-7cf6e97537b3-0

00:13:10.480 --> 00:13:15.200
Her CT which is here showed some ground glass opacity.
651b48ed-251a-4601-8d67-1e695295bf9e-0

00:13:15.680 --> 00:13:20.603
There was areas of fibrosis with some traction bronchiectasis and traction
651b48ed-251a-4601-8d67-1e695295bf9e-1

00:13:20.603 --> 00:13:21.720
bronchiolectasis.
7a107178-e46a-4e58-95d8-3748aa10ea5e-0

00:13:21.720 --> 00:13:26.886
There was, you know,
basal predominance but also some mid lung
7a107178-e46a-4e58-95d8-3748aa10ea5e-1

00:13:26.886 --> 00:13:28.280
zone involvement.
54ad07ad-5c5a-4b68-ba96-7bd6e2cf1688-0 

00:13:28.760 --> 00:13:33.682
It was para bronchovascular plus subpleural and the overall interpretation
54ad07ad-5c5a-4b68-ba96-7bd6e2cf1688-1 

00:13:33.682 --> 00:13:38.210
of the CT was most in keeping with an alternative to UIP pattern and
54ad07ad-5c5a-4b68-ba96-7bd6e2cf1688-2 

00:13:38.210 --> 00:13:43.394 
indeterminate for HP as there was no real convincing evidence of small airways
54ad07ad-5c5a-4b68-ba96-7bd6e2cf1688-3 

00:13:43.394 --> 00:13:43.919
disease.
5ce3490c-7c29-4d66-b7cc-8d22f96d8a84-0 

00:13:45.440 --> 00:13:46.840
She had serology done.
0e6c086a-e0f0-42a8-8fe1-7bae6c984a8d-0 

00:13:47.720 --> 00:13:52.600
This patient did undergo bronchoscopy and really had no significant lymphocytosis.
dabf94bd-da7a-4494-9c5d-6806a571101d-0 

00:13:58.540 --> 00:14:02.387
All right,
so this is the polling question #2 So
dabf94bd-da7a-4494-9c5d-6806a571101d-1 

00:14:02.387 --> 00:14:02.780
what?
8a3766c2-1819-41f4-affb-af7d4ea00190-0 

00:14:02.900 --> 00:14:03.740
What would you do?
16ed75fa-2e7b-42bd-ae3d-3f60b3538a7a-0 

00:14:03.740 --> 00:14:07.040
What would you say to the referring physician?
fa0d4806-368c-446a-a99f-0e3ca75e3a37-0 

00:14:07.040 --> 00:14:08.960
Yes, send them for surgical lung biopsy.
9951ece9-e276-4c36-8b68-b96fdd542358-0

00:14:08.960 --> 00:14:12.160
No,
don't send them for surgical lung biopsy.
4f36a4e9-5e3d-4c80-965b-5e992a585fc9-0

00:14:12.360 --> 00:14:15.080
Or lastly, send them for cryobiopsy.
05f438e4-1be9-4430-95f7-ab62dd8fc1d9-0 

00:14:15.080 --> 00:14:21.960
I think this one will be a little bit more mixed, so I'm excited.
e22df2fc-fda5-4e77-8e31-4f6cd82454de-0 

00:14:23.880 --> 00:14:28.560
We'll give everyone a minute or so for the results to come in.
4b734c3a-7776-4e91-b94b-35570b77aff3-0

00:14:33.990 --> 00:14:46.316
Get some more people voting all right see some more coming in your get your vote in
4b734c3a-7776-4e91-b94b-35570b77aff3-1

00:14:46.316 --> 00:14:57.909
even even if the options aren't great, we should all still get out and vote so
4b734c3a-7776-4e91-b94b-35570b77aff3-2

00:14:57.909 --> 00:15:05.099
come on OK,
I think we can we can close the poll
4b734c3a-7776-4e91-b94b-35570b77aff3-3

00:15:05.099 --> 00:15:05.979
there.
a6c886ff-4568-47b8-b5d2-d15b035fc2bb-0 

00:15:05.980 --> 00:15:08.500
We got a good number of responses.
8cb972d6-8e7e-4631-a968-34a3a08d53dc-0

00:15:12.380 --> 00:15:15.100
All right, so this is interesting.
c3c12b6c-9252-40b9-8a59-3c273cdbfdc2-0 

00:15:15.100 --> 00:15:21.776
So most people, so 62% said yes,
send for surgical lung biopsy, 14% no,
c3c12b6c-9252-40b9-8a59-3c273cdbfdc2-1 

00:15:21.776 --> 00:15:26.320
wouldn't do the lung biopsy, not worth the risk.
8348387b-2114-436f-9fb4-96eb8ef49c01-0

00:15:26.320 --> 00:15:30.240
And then 24% said send for send for cryobiopsy.
07a6afaf-084b-40fb-a39e-40d38276798f-0 

00:15:30.240 --> 00:15:39.020
All right, OK.
1892f197-2130-4263-84c5-0e66a4ef7c91-0

00:15:39.020 --> 00:15:43.380
So let's just loop back to our figures here just to remind ourselves when we
1892f197-2130-4263-84c5-0e66a4ef7c91-1

00:15:43.380 --> 00:15:47.740
when we might be thinking about doing something like cryobiopsy or surgical
1892f197-2130-4263-84c5-0e66a4ef7c91-2

00:15:47.740 --> 00:15:48.420
lung biopsy.
1983072b-396e-488d-933f-01719e9e9c4d-0

00:15:48.900 --> 00:15:54.881
So for when IPF is on the differential indeterminate for UIP or alternate
1983072b-396e-488d-933f-01719e9e9c4d-1

00:15:54.881 --> 00:16:00.540
diagnosis, which our patient fell into, discuss it in MDD if you can,
1983072b-396e-488d-933f-01719e9e9c4d-2

00:16:00.540 --> 00:16:02.480
then you think about it.
76bf0270-2e4b-4a0a-8033-72a9625c7493-0

00:16:02.480 --> 00:16:06.515
And then if we're thinking about it from an HP lens, you know,
76bf0270-2e4b-4a0a-8033-72a9625c7493-1

00:16:06.515 --> 00:16:09.525
we've gone through exposure, looked at the CT,
76bf0270-2e4b-4a0a-8033-72a9625c7493-2

00:16:09.525 --> 00:16:13.240
we've done a bronchoscopy with the BAL cellular analysis.
c773b914-9b97-4ca0-90e2-befa9cae6417-0 

00:16:13.560 --> 00:16:15.440
We've had an MDD discussion.
e40aba55-86d6-4965-a2ea-71e556bdb422-0 

00:16:15.600 --> 00:16:19.200We still haven't found a diagnosis and that's when we're thinking about it.
0de95d32-9132-4f21-9dac-ddc0abbf50cc-0 

00:16:20.320 --> 00:16:24.071
All right,
So ATS suggests we should be thinking
0de95d32-9132-4f21-9dac-ddc0abbf50cc-1 

00:16:24.071 --> 00:16:24.760
about it.
1d58db0e-1bb2-4c4f-9fc2-2b2f455d22d1-0 

00:16:25.840 --> 00:16:27.880
Why are we, you know, hesitant?
cea781df-e162-45a8-8198-1f3292ed4842-0 

00:16:28.480 --> 00:16:31.160
So really what is the risk of surgical lung biopsy?
90ccb91f-7702-4e99-89e8-9005e52d794a-0

00:16:31.760 --> 00:16:37.153
And I think this was a really important paper that was published in the US in
90ccb91f-7702-4e99-89e8-9005e52d794a-1

00:16:37.153 --> 00:16:39.920
2016 looking at inpatient hospital data.
43c4f9f5-6602-4fc6-837f-c8c0f19ff0f3-0 

00:16:40.840 --> 00:16:47.631
And so they looked at all patients who had a surgical lung biopsy for ILD using
43c4f9f5-6602-4fc6-837f-c8c0f19ff0f3-1 

00:16:47.631 --> 00:16:49.160
the hospital data.
284a0c62-df08-46b4-8dbe-5c2b8bfb97c3-0 

00:16:49.160 --> 00:16:54.720
So it wouldn't include any data after patients are discharged from hospitals.
94baa285-6b2b-48f0-949d-9539ff222223-0

00:16:54.720 --> 00:16:57.240
So this is just looking at their hospital stay.
f67704b6-4931-4680-84e9-471b1d7f7c28-0 

00:16:58.160 --> 00:17:03.573
And what they found was that the inpatient mortality after surgical lung
f67704b6-4931-4680-84e9-471b1d7f7c28-1 

00:17:03.573 --> 00:17:04.760
biopsy was 6.4%.
4b1dfc96-8db7-4e44-8272-1fe241db01cb-0 

00:17:05.120 --> 00:17:08.055
So, you know,
really quite high for a diagnostic
4b1dfc96-8db7-4e44-8272-1fe241db01cb-1

00:17:08.055 --> 00:17:12.667
procedure, especially when we think of, you know, lobectomy for lung cancer,
4b1dfc96-8db7-4e44-8272-1fe241db01cb-2 

00:17:12.667 --> 00:17:17.640
which is a potentially curative procedure, has a 30 day mortality of less than 2%.
687ec2e2-60be-49e6-b370-8ba3b38e6a3b-0 

00:17:17.640 --> 00:17:21.130
So you know,
this this was really a striking number
687ec2e2-60be-49e6-b370-8ba3b38e6a3b-1 

00:17:21.130 --> 00:17:25.360
when they stratified patients by elective versus non elective.
92863364-89b6-47bb-9045-e27cc3ad85c1-0

00:17:25.360 --> 00:17:29.107
So elective would be those patients who are coming from home, you know,
92863364-89b6-47bb-9045-e27cc3ad85c1-1

00:17:29.107 --> 00:17:32.073
for the lung biopsy,
whereas non elective would be those
92863364-89b6-47bb-9045-e27cc3ad85c1-2

00:17:32.073 --> 00:17:34.520
patients who are already admitted to hospital.
bdd53886-3391-4cb6-88d6-81a1530eebc4-0 

00:17:34.760 --> 00:17:38.675
You get consulted, you know,
as the respirologist who's on and you
bdd53886-3391-4cb6-88d6-81a1530eebc4-1 

00:17:38.675 --> 00:17:41.422
know, should we be sending this patient
bdd53886-3391-4cb6-88d6-81a1530eebc4-2 

00:17:41.422 --> 00:17:43.000
for a surgical lung biopsy
3c655c50-e234-4c51-949d-eed21a858021-0

00:17:43.000 --> 00:17:46.749
So that that would be the non elective and you know the difference is really
3c655c50-e234-4c51-949d-eed21a858021-1

00:17:46.749 --> 00:17:47.480
quite striking.
17bddcbe-f7da-4e89-be37-afabc03595ef-0 

00:17:48.200 --> 00:17:50.400
You can see it represented in this figure here.
3149999d-f721-4ec6-85d2-3d000920ff00-0

00:17:50.400 --> 00:17:55.176
So in hospital mortality in the elective patients was 1.7%
3149999d-f721-4ec6-85d2-3d000920ff00-1

00:17:55.176 --> 00:18:01.293
versus about 16% in patients who underwent non elective surgical lung
3149999d-f721-4ec6-85d2-3d000920ff00-2

00:18:01.293 --> 00:18:01.880
biopsy.
d9eefbe8-1c35-46af-b4c2-89d0b868c55a-0 

00:18:01.880 --> 00:18:04.560
So very high in in non elective case.
34b86d2f-5a52-4c88-b77e-0449e9513d4d-0

00:18:05.080 --> 00:18:08.664
And they also looked at specific risk factors for mortality and they were,
34b86d2f-5a52-4c88-b77e-0449e9513d4d-1

00:18:08.664 --> 00:18:10.480
as you would expect, so comorbidities.
93da0975-0731-4563-9064-2b611ca73ed6-0

00:18:10.480 --> 00:18:13.752
So, you know,
five times higher odds of in hospital
93da0975-0731-4563-9064-2b611ca73ed6-1

00:18:13.752 --> 00:18:16.900
death if your Charleson score was more than two,
93da0975-0731-4563-9064-2b611ca73ed6-2

00:18:16.900 --> 00:18:19.040
your Charleston comorbidity score.
c8a5b306-dd7a-4d31-a796-f20abfad1d76-0 

00:18:19.440 --> 00:18:22.840
And then for age, so older age, which again is not surprising.
35967d4c-dad6-47fd-b7c3-78dc515b0eeb-0 

00:18:22.840 --> 00:18:27.197
So three time higher odds of death if you're over 65 and then 4 1/2 times
35967d4c-dad6-47fd-b7c3-78dc515b0eeb-1 

00:18:27.197 --> 00:18:30.200
higher odds of death if you're over the age of 75.
61d621e7-779c-4fe1-b132-e51f8d9ae7ba-0 

00:18:35.040 --> 00:18:39.960
We've looked at data here in Ontario using health administrative data.
b4fd7777-208d-4a31-88ea-b612df236bea-0 

00:18:39.960 --> 00:18:44.084
And so because we capture, you know, all the interactions with the health
b4fd7777-208d-4a31-88ea-b612df236bea-1 

00:18:44.084 --> 00:18:46.760
system,
we can look at the in hospital and then
b4fd7777-208d-4a31-88ea-b612df236bea-2 

00:18:46.760 --> 00:18:48.600
post hospital experience as well.
65e442f0-5bb3-4ca4-b9a7-5b10bc7c104d-0 

00:18:48.600 --> 00:18:52.371
And so we looked at 30 day mortality and we got, you know,
65e442f0-5bb3-4ca4-b9a7-5b10bc7c104d-1 

00:18:52.371 --> 00:18:55.440
fairly similar numbers compared to the US data.
822b7463-149d-4ed9-bea0-170eb3fd08c0-0 

00:18:55.440 --> 00:19:02.874
So our 30 day mortality was 7% overall and then 2% in elective procedures versus
822b7463-149d-4ed9-bea0-170eb3fd08c0-1 

00:19:02.874 --> 00:19:05.720
20% in non elective procedures.
e0e2961b-1266-48c0-b412-56d3db897156-0 

00:19:06.720 --> 00:19:10.200
And when we looked at specific risk factors for mortality.
38b466be-2426-4ddf-b5a5-55921d470df3-0

00:19:10.200 --> 00:19:15.248
So in addition to having a non elective procedure, being on home oxygen,
38b466be-2426-4ddf-b5a5-55921d470df3-1

00:19:15.248 --> 00:19:18.774
being male,
older age and older comorbidities were
38b466be-2426-4ddf-b5a5-55921d470df3-2

00:19:18.774 --> 00:19:22.440
all associated with higher odds of death at 30 days.
bfa5338d-8c34-41fb-942c-6667a7e207e1-0 

00:19:23.440 --> 00:19:27.160
We also looked at center experience.
63808f22-33ff-4206-9d93-2d0f718b3c8e-0

00:19:27.360 --> 00:19:30.636
So we looked at the number of surgical lung,
63808f22-33ff-4206-9d93-2d0f718b3c8e-1

00:19:30.636 --> 00:19:36.243
number of surgical lung biopsies the center does in a year and we found that
63808f22-33ff-4206-9d93-2d0f718b3c8e-2

00:19:36.243 --> 00:19:41.849
centers who had higher surgical lung biopsy experience had improved survival
63808f22-33ff-4206-9d93-2d0f718b3c8e-3

00:19:41.849 --> 00:19:46.000
and it was particularly relevant for non elective cases.
6795caf4-74e8-4ba9-bce2-c666b65d6f69-0 

00:19:46.000 --> 00:19:48.737
And you know,
there's a lot of factors that go into
6795caf4-74e8-4ba9-bce2-c666b65d6f69-1 

00:19:48.737 --> 00:19:51.160
that volume outcome relationship and surgery.
2f2c2568-d12a-4116-a091-4051a692f77a-0

00:19:51.160 --> 00:19:53.897
So it's not, you know,
just about surgical expertise,
2f2c2568-d12a-4116-a091-4051a692f77a-1

00:19:53.897 --> 00:19:57.345
but it's probably about, you know, patient selection, so, you know,
2f2c2568-d12a-4116-a091-4051a692f77a-2

00:19:57.345 --> 00:20:01.249
selecting the right patients to undergo the procedure and then also just the
2f2c2568-d12a-4116-a091-4051a692f77a-3

00:20:01.249 --> 00:20:02.720
experience of the whole team.
b3df0543-15d1-491c-a5b1-29315a9b7f75-0 

00:20:02.720 --> 00:20:06.650
So the anaesthetist and the, you know, pre and post surgical care that the
b3df0543-15d1-491c-a5b1-29315a9b7f75-1 

00:20:06.650 --> 00:20:07.960
patients receive as well.
5b06f6a6-24aa-4474-9ba9-4489914ccb89-0

00:20:13.800 --> 00:20:17.855
Summarizing all that data together just to highlight again the major risk factors
5b06f6a6-24aa-4474-9ba9-4489914ccb89-1

00:20:17.855 --> 00:20:19.400
for perioperative complications.
b6c46427-e8c5-44d7-a3c3-a01fea5b9634-0 

00:20:19.400 --> 00:20:23.354
So when patients have these,
we really are hesitant and essentially
b6c46427-e8c5-44d7-a3c3-a01fea5b9634-1 

00:20:23.354 --> 00:20:26.960
would not send them for a surgical lung biopsy at our center.
e3069d83-74dd-44a6-a00e-fd4b9c298dc6-0 

00:20:26.960 --> 00:20:31.632
So age over 75 years,
really significant comorbidities,
e3069d83-74dd-44a6-a00e-fd4b9c298dc6-1 

00:20:31.632 --> 00:20:32.800
lung function.
06ac99ed-38e8-4415-aae5-01e47f4e3a0f-0 

00:20:32.800 --> 00:20:38.001
So there's observational data that has shown that an FVC of less than 55% and a
06ac99ed-38e8-4415-aae5-01e47f4e3a0f-1 

00:20:38.001 --> 00:20:43.073
diffusing capacity of less than 35% is associated with higher mortality after
06ac99ed-38e8-4415-aae5-01e47f4e3a0f-2 

00:20:43.073 --> 00:20:46.000
lung biopsy,
preoperative resting hypoxemia.
e92f2cd2-082b-4d7b-ac0c-39d165399e9a-0 

00:20:46.000 --> 00:20:51.143
So those patients who are on home oxygen, certainly preoperative mechanical
e92f2cd2-082b-4d7b-ac0c-39d165399e9a-1 

00:20:51.143 --> 00:20:54.358
ventilation,
very high association with increased
e92f2cd2-082b-4d7b-ac0c-39d165399e9a-2 

00:20:54.358 --> 00:20:58.602
mortality after lung biopsy and then pulmonary hypertension, being
e92f2cd2-082b-4d7b-ac0c-39d165399e9a-3 

00:20:58.602 --> 00:20:59.760
immunocompromised.
418c0d3c-806e-4bd1-8c17-2d26c6c27f89-0

00:20:59.760 --> 00:21:02.124
So you know,
patients who are already on Prednisone
418c0d3c-806e-4bd1-8c17-2d26c6c27f89-1

00:21:02.124 --> 00:21:04.579
are bone marrow,
we have a big bone marrow transplant
418c0d3c-806e-4bd1-8c17-2d26c6c27f89-2

00:21:04.579 --> 00:21:05.079
population.
ed357f38-b41c-48d9-b0eb-5f54cbfdc72b-0 

00:21:05.080 --> 00:21:08.836
We find that they do very poorly after lung biopsy and then certainly rapidly
ed357f38-b41c-48d9-b0eb-5f54cbfdc72b-1 

00:21:08.836 --> 00:21:09.800
progressive disease.
d8da4f1a-5864-45fe-b621-0571501167d0-0

00:21:09.800 --> 00:21:12.390
So, you know, these patients who are, you know,
d8da4f1a-5864-45fe-b621-0571501167d0-1 

00:21:12.390 --> 00:21:14.818
maybe in the spectrum of acute exacerbation,
d8da4f1a-5864-45fe-b621-0571501167d0-2 

00:21:14.818 --> 00:21:17.840
surgical lung biopsy can really tip them over the edge.
749079da-e387-496e-8e33-763dc7f44645-0

00:21:21.680 --> 00:21:23.280
All right, so let's loop back.
594a1cd6-d97e-40ff-b8e6-eb3ee4ea5723-0 

00:21:23.480 --> 00:21:25.320
So when to consider a surgical lung biopsy?
ce1f12ed-8346-40ef-a1a0-89a236d36b73-0 

00:21:25.320 --> 00:21:26.680
So what do the guidelines say?
24fc93b1-9e4c-444b-9a9c-7f000d62f9cb-0 

00:21:27.360 --> 00:21:30.890
So for HP,
they say for patients with newly
24fc93b1-9e4c-444b-9a9c-7f000d62f9cb-1 

00:21:30.890 --> 00:21:35.464
identified ILD,
when the differential diagnosis includes
24fc93b1-9e4c-444b-9a9c-7f000d62f9cb-2 

00:21:35.464 --> 00:21:39.877
fibrotic HP,
the guideline committee suggests surgical
24fc93b1-9e4c-444b-9a9c-7f000d62f9cb-3 

00:21:39.877 --> 00:21:40.839
lung biopsy.
8129792f-4011-4183-8703-c19c2fb09b71-0

00:21:41.280 --> 00:21:46.864
When you've done all those other tests that we talked about, you know,
8129792f-4011-4183-8703-c19c2fb09b71-1

00:21:46.864 --> 00:21:52.842
extensive exposure evaluation post look
at the CT bronchoscopy with BAL and
8129792f-4011-4183-8703-c19c2fb09b71-2

00:21:52.842 --> 00:21:58.820
cellular analysis and and you really can't find a diagnosis then suggest so
8129792f-4011-4183-8703-c19c2fb09b71-3

00:21:58.820 --> 00:22:02.359
that's like the softer one not, not recommend.
0bae7c17-24f7-4094-b8a5-00e8c8cdbba2-0 

00:22:04.000 --> 00:22:10.517
And then for the IPF guidelines,
they suggest performing surgical lung
0bae7c17-24f7-4094-b8a5-00e8c8cdbba2-1 

00:22:10.517 --> 00:22:11.160
biopsy.
39d1b2fa-449c-421c-8f68-040c664ef2ff-0

00:22:11.160 --> 00:22:16.572
So this is the conditional recommendation if it's indeterminate for UIP or
39d1b2fa-449c-421c-8f68-040c664ef2ff-1 

00:22:16.572 --> 00:22:18.160
alternative diagnosis.
9e5120ae-e23c-45a9-bda8-71e8ed260e42-0 

00:22:18.480 --> 00:22:21.746
And then probably UIP gets an* which you know,
9e5120ae-e23c-45a9-bda8-71e8ed260e42-1 

00:22:21.746 --> 00:22:25.221
in subsequent sort of discussions and iterations,
9e5120ae-e23c-45a9-bda8-71e8ed260e42-2 

00:22:25.221 --> 00:22:30.643
I think everyone acknowledges that most patients with probably UIP would not,
9e5120ae-e23c-45a9-bda8-71e8ed260e42-3 

00:22:30.643 --> 00:22:32.520
should not go for a biopsy.
90ff7314-5bb5-4074-880f-32212d56a225-0

00:22:33.280 --> 00:22:39.631
And then a strong recommendation not to perform a biopsy when patients have a, 
90ff7314-5bb5-4074-880f-32212d56a225-1

00:22:39.631 --> 00:22:41.240
a UIP pattern on CT.
0debea11-ce57-49c1-84b7-66dce8ee85ca-0 

00:22:45.960 --> 00:22:47.840
OK, so how about what do I do?
da894d0e-18af-4598-ab80-43a4c75c67a8-0 

00:22:48.240 --> 00:22:49.280
A pragmatist.
8115f04d-1011-4405-963a-dca30fbc944d-0

00:22:50.960 --> 00:22:57.474
So I do consider lung biopsy for indeterminant or alternative UIP cases
8115f04d-1011-4405-963a-dca30fbc944d-1

00:22:57.474 --> 00:23:00.280
and or low confidence HP cases.
bde00cec-2b96-467e-abf5-06d0e29d12a2-0 

00:23:00.840 --> 00:23:04.820
I always discuss these cases in MDD - I realize that's not, you know,
bde00cec-2b96-467e-abf5-06d0e29d12a2-1 

00:23:04.820 --> 00:23:08.384
universally available,
but if you have access to an MDD and
bde00cec-2b96-467e-abf5-06d0e29d12a2-2 

00:23:08.384 --> 00:23:12.839
you're considering a lung biopsy,
I think those cases should be discussed.
daa8e224-8331-4f46-a738-bbc0e333e0d3-0 

00:23:13.680 --> 00:23:18.668
I think it's important really to consider the safety profile and center expertise
daa8e224-8331-4f46-a738-bbc0e333e0d3-1 

00:23:18.668 --> 00:23:21.710
and, you know,
really look at your patient safety
daa8e224-8331-4f46-a738-bbc0e333e0d3-2 

00:23:21.710 --> 00:23:25.299
profile, you know,
have a frank discussion with them about
daa8e224-8331-4f46-a738-bbc0e333e0d3-3 

00:23:25.299 --> 00:23:26.760
the risk versus benefit.
0ae4e607-b056-4305-b4c2-fa694a8fc14a-0 

00:23:26.760 --> 00:23:30.040
And I always ask myself,
is this result going to change management?
9da80830-fd85-4856-8bf9-844970907e01-0

00:23:30.800 --> 00:23:34.180
If no matter what the biopsy says, I'm just going to do the same thing
9da80830-fd85-4856-8bf9-844970907e01-1

00:23:34.180 --> 00:23:36.371
anyway,
then then I personally would not send
9da80830-fd85-4856-8bf9-844970907e01-2

00:23:36.371 --> 00:23:37.800
that person for a lung biopsy.
4df2ea37-d5b5-4537-b5f6-c3ebcff6fd68-0 

00:23:40.720 --> 00:23:42.520
OK, So then what about cryobiopsy?
cda31668-e96e-4c51-8a11-9b48a6d93186-0 

00:23:42.520 --> 00:23:46.560
So some of you suggested cryobiopsy for that that patient.
16a57adc-3b79-45c3-b1da-b300d9bbe825-0 

00:23:47.160 --> 00:23:51.537
So transbronchial lung cryobiopsy is a potential alternative to surgical lung
16a57adc-3b79-45c3-b1da-b300d9bbe825-1 

00:23:51.537 --> 00:23:51.920
biopsy.
d9446dc4-4325-4c62-a53b-ee28234af89c-0 

00:23:51.920 --> 00:23:56.920
So it's similar to transbronchial biopsy but employs a freezing probe and thus
d9446dc4-4325-4c62-a53b-ee28234af89c-1 

00:23:56.920 --> 00:24:00.920
obtains lung tissue samples that are larger and better quality.
67d0adc7-0e28-4d77-916e-873a6f786e09-0

00:24:01.240 --> 00:24:05.890
And so the overarching idea behind it is that it's less invasive,
67d0adc7-0e28-4d77-916e-873a6f786e09-1 

00:24:05.890 --> 00:24:11.246
potentially safer than surgical lung biopsy and can get you a larger tissue
67d0adc7-0e28-4d77-916e-873a6f786e09-2

00:24:11.246 --> 00:24:15.615
size that will be adequate for your pathologist to, you know,
67d0adc7-0e28-4d77-916e-873a6f786e09-3

00:24:15.615 --> 00:24:17.800
help with making the diagnosis.
df7a920b-73bd-43c6-aafd-c07047490fd5-0 

00:24:17.800 --> 00:24:23.051
And so if we think about transmolecular biopsy, so you know,
df7a920b-73bd-43c6-aafd-c07047490fd5-1 

00:24:23.051 --> 00:24:30.197
probably depends on how good you are or how, how aggressive you are, but you know,
df7a920b-73bd-43c6-aafd-c07047490fd5-2 

00:24:30.197 --> 00:24:34.760
you might get a sample that's 1mm to, you know, 2mm.
7bba609d-e57a-4f4e-8a91-3aa5d897cf64-0 

00:24:36.040 --> 00:24:38.907
And then with transbronchial and cryobiopsy,
7bba609d-e57a-4f4e-8a91-3aa5d897cf64-1 

00:24:38.907 --> 00:24:42.080
it depends on how long you deploy the freezing for.
744e05ed-2bce-4f7d-8d63-21b8b5074027-0

00:24:42.480 --> 00:24:45.404
And then the longer you deploy the freezing probe,
744e05ed-2bce-4f7d-8d63-21b8b5074027-1

00:24:45.404 --> 00:24:47.240
the higher the risk of bleeding.
6b796900-2fb2-46b4-ac6f-ff68290634e4-0

00:24:47.240 --> 00:24:51.120
So you know,
there's going to be variation there again,
6b796900-2fb2-46b4-ac6f-ff68290634e4-1

00:24:51.120 --> 00:24:55.000
but you know,
you're probably looking at something more
6b796900-2fb2-46b4-ac6f-ff68290634e4-2

00:24:55.000 --> 00:24:56.040
like 8mm to 12mm.
75e706c0-dbf5-4923-96aa-626a27effe38-0 

00:24:56.040 --> 00:25:00.941
And then obviously, you know, we get a nice large chunk from our
75e706c0-dbf5-4923-96aa-626a27effe38-1 

00:25:00.941 --> 00:25:07.350
surgical lung biopsy, which is, you know, going to be several centimeters, you know,
75e706c0-dbf5-4923-96aa-626a27effe38-2 

00:25:07.350 --> 00:25:09.160
more like 5 centimeters.
da1f9c94-2b64-4c45-af7f-c21259d9666d-0 

00:25:13.200 --> 00:25:15.440
All right,
And hopefully this video works for you.
95f7c5ee-fb1c-4d1f-8940-ae43120adcb9-0 

00:25:15.440 --> 00:25:18.350
But for those of you who haven't seen a crowd probe,
95f7c5ee-fb1c-4d1f-8940-ae43120adcb9-1 

00:25:18.350 --> 00:25:21.480
so this is a crowd probe here just showing the freezing.
915111cc-9b79-45ae-a15a-f7cd6cae1996-0 

00:25:21.480 --> 00:25:23.040
So basically you deploy the freezing.
550d13bf-6723-4215-aadc-54e16a8159db-0

00:25:23.040 --> 00:25:26.360
You can see that's like an ice bubble on the end.
845611c0-a91c-4185-b7d6-ddd4040f309c-0

00:25:26.840 --> 00:25:33.196
And so the idea is that you put it through, you do a regular bronchoscopy,
845611c0-a91c-4185-b7d6-ddd4040f309c-1

00:25:33.196 --> 00:25:37.348
you put it through the, the, the chamber in the, 
845611c0-a91c-4185-b7d6-ddd4040f309c-2

00:25:37.348 --> 00:25:41.586
the therapeutic chamber or the diagnostic, sorry,
845611c0-a91c-4185-b7d6-ddd4040f309c-3

00:25:41.586 --> 00:25:45.400
the therapeutic chamber in the bronchoscope.
e81cd4b3-dfae-40a5-942d-f2a20911e186-0 

00:25:46.120 --> 00:25:49.001
You deploy,
you go to wherever you want to take the
e81cd4b3-dfae-40a5-942d-f2a20911e186-1 

00:25:49.001 --> 00:25:51.716
biopsy,
you deploy the freezing and it freezes a
e81cd4b3-dfae-40a5-942d-f2a20911e186-2 

00:25:51.716 --> 00:25:52.880
chunk of lung tissue.
1b5debed-fabf-4b96-989d-8e23637b82ba-0 

00:25:52.880 --> 00:25:56.000
And then you pull the whole thing out the, the bronchoscope as well.
89d92817-169d-4beb-86cd-763a3cdfb8d5-0 

00:25:56.880 --> 00:26:00.080
And then you get a larger piece of lung tissue.
00a98f42-ad69-440e-80b3-f90fc2709618-0

00:26:00.720 --> 00:26:06.721
Shane likes to describe it as like the
image he has of Homer Simpson putting his
00a98f42-ad69-440e-80b3-f90fc2709618-1

00:26:06.721 --> 00:26:09.240
tongue on a frozen pole in winter.
d23c89f3-d0b8-45ad-b5f4-e18073bb2f1e-0 

00:26:09.600 --> 00:26:12.520
And then, you know,
a chunk of the tongue gets ripped off.
b01ca041-c3de-4b84-92e4-97a23c7e4efd-0 

00:26:12.560 --> 00:26:14.280
So it's also a good way to remember it. c8648c9f-bdbb-40fc-8f6c-9e5ce29a62dc-0 

00:26:16.440 --> 00:26:20.971
And so I say that the cold ice study was sort of really the big study with
c8648c9f-bdbb-40fc-8f6c-9e5ce29a62dc-1 

00:26:20.971 --> 00:26:25.503
transbronchial lung cryobiopsy where, you know, we thought, OK, you know,
c8648c9f-bdbb-40fc-8f6c-9e5ce29a62dc-2 

00:26:25.503 --> 00:26:27.800
maybe we can use this in our patients.
5d3a2f9f-dc24-4aa4-a7a1-e69d5bd24e38-0 

00:26:27.800 --> 00:26:31.860
And so this was a prospective study of 65 patients who underwent concurrent
5d3a2f9f-dc24-4aa4-a7a1-e69d5bd24e38-1 

00:26:31.860 --> 00:26:34.960
transbronchial lung cryobiopsy and surgical lung biopsy.
c70073bc-fcf6-44d4-9676-e5800ecd3ffc-0 

00:26:35.760 --> 00:26:39.858
And you know, in brief,
the results were that there was
c70073bc-fcf6-44d4-9676-e5800ecd3ffc-1 

00:26:39.858 --> 00:26:44.981
histopathologic agreement between transbronchial lung cryobiopsy and
c70073bc-fcf6-44d4-9676-e5800ecd3ffc-2 

00:26:44.981 --> 00:26:51.056
surgical lung biopsy 81% of the time and then there was diagnostic agreement after
c70073bc-fcf6-44d4-9676-e5800ecd3ffc-3 

00:26:51.056 --> 00:26:52.520
MDD 77% of the time.
12fa8cf3-95c5-4e49-8730-61b30a95631f-0

00:26:52.520 --> 00:26:55.040
So, you know, pretty reasonable results.
b4c686b8-9779-425d-b751-3f38023a1b96-0 

00:26:57.040 --> 00:27:01.680
The concordance with a surgical lung biopsy MDD was quite high.
5f8320dd-673f-4ac1-86bb-266989175c0a-0

00:27:01.680 --> 00:27:07.644
So 95% if there was a high confidence in
the diagnosis after transbronchial cryo
5f8320dd-673f-4ac1-86bb-266989175c0a-1

00:27:07.644 --> 00:27:08.160
biopsy.
245f09ba-c540-4a68-89ff-928ac063586b-0

00:27:09.760 --> 00:27:15.282
In those patients who had low confidence in diagnosis with the transbronchial lung
245f09ba-c540-4a68-89ff-928ac063586b-1

00:27:15.282 --> 00:27:20.005
cryobiopsy MDD about 1/4 change to an alternative diagnosis with high
245f09ba-c540-4a68-89ff-928ac063586b-2

00:27:20.005 --> 00:27:22.800
confidence after the surgical lung biopsy.
faee7e1f-cee9-4530-bef4-4e0e803db497-0 

00:27:24.240 --> 00:27:28.444
And so, you know,
really it seems like concordance was very
faee7e1f-cee9-4530-bef4-4e0e803db497-1 

00:27:28.444 --> 00:27:33.840
high if everyone felt good about the transbronchial lung cryobiopsy result.
3204f2cb-ed1d-4b8c-b335-75498b1fc938-0 

00:27:34.120 --> 00:27:38.111
However, if you know,
the there was low confidence in the
3204f2cb-ed1d-4b8c-b335-75498b1fc938-1 

00:27:38.111 --> 00:27:42.240
diagnosis, then, you know, the results weren't as striking.
e4add33b-7752-4afc-b56d-59ad708b80a1-0 

00:27:42.720 --> 00:27:46.225
There was in terms of complications, there was mild to moderate bleeding in
e4add33b-7752-4afc-b56d-59ad708b80a1-1 

00:27:46.225 --> 00:27:47.240
about 1/4 of patients.
bc9de60a-a145-44d5-842f-4390c638a541-0 

00:27:47.240 --> 00:27:49.960
That was really sort of the most significant complication. 
b37b8978-a74f-42dd-819b-75428e397786-0 

00:27:50.760 --> 00:27:54.914
And so, you know, as a result,
I would say transbronchial cryobiopsy
b37b8978-a74f-42dd-819b-75428e397786-1 

00:27:54.914 --> 00:27:57.080
is certainly emerging or has emerged.
ba4d6b00-baad-4f3a-a253-9a1adf10b88a-0 

00:27:57.080 --> 00:27:59.964
It's a possible alternative to surgical lung biopsy,
ba4d6b00-baad-4f3a-a253-9a1adf10b88a-1 

00:27:59.964 --> 00:28:03.720
but does require obviously the expertise and appropriate safeguards.
573c8043-3ad8-4616-a845-b34353d77047-0

00:28:03.720 --> 00:28:07.320
And so, you know,
won't be available in every center.
68495972-8252-4f9e-a068-a4731e914e75-0

00:28:07.960 --> 00:28:12.112
You know with the asterisks that you should be careful about those trans
68495972-8252-4f9e-a068-a4731e914e75-1

00:28:12.112 --> 00:28:16.550
bronchial lung cryobiopsy path
results with low confidence and you know,
68495972-8252-4f9e-a068-a4731e914e75-2

00:28:16.550 --> 00:28:18.200
it's certainly in our center.
0ad27336-0984-4c97-9f68-03455a05d7a6-0

00:28:18.200 --> 00:28:22.128
We do think that the distribution of disease may help with patient selection
0ad27336-0984-4c97-9f68-03455a05d7a6-1

00:28:22.128 --> 00:28:23.200
and diagnostic yield.
ead587dd-c3dc-4fcf-8a7a-2e8eadac152a-0 

00:28:23.200 --> 00:28:26.598
So, you know,
we are more likely to send patients who
ead587dd-c3dc-4fcf-8a7a-2e8eadac152a-1 

00:28:26.598 --> 00:28:29.871
have parabronchiovascular involvement, for example,
ead587dd-c3dc-4fcf-8a7a-2e8eadac152a-2 

00:28:29.871 --> 00:28:34.466
for cryobiopsy as opposed to where the disease is like really, you know,
ead587dd-c3dc-4fcf-8a7a-2e8eadac152a-3 

00:28:34.466 --> 00:28:36.040
peripheral and subplural.
f2ccf5b2-dcb7-4456-a7ad-ec2625cd7dcf-0 

00:28:44.000 --> 00:28:47.419
I thought I'd tell you about the cold study as well,
f2ccf5b2-dcb7-4456-a7ad-ec2625cd7dcf-1 

00:28:47.419 --> 00:28:52.000
which is a more recent publication from some people in the same group.
dff1d051-5a93-442f-bfd1-46a7be5e65f9-0 

00:28:52.000 --> 00:28:57.244
So this was a multi center RCT in the Netherlands and what they did is they
dff1d051-5a93-442f-bfd1-46a7be5e65f9-1 

00:28:57.244 --> 00:29:02.557
took 55 patients who after MDD where it was suggested they should have a lung
dff1d051-5a93-442f-bfd1-46a7be5e65f9-2 

00:29:02.557 --> 00:29:03.040
biopsy.
0f3b15d8-6535-4258-a666-2486818d64e3-0

00:29:03.520 --> 00:29:07.544
And they randomized them either to get immediate surgical lung biopsy versus
0f3b15d8-6535-4258-a666-2486818d64e3-1

00:29:07.544 --> 00:29:11.360
what they called the step up strategy where they did a cryobiopsy first.
fb51e9e1-92a6-4b9c-8a23-7e2466a404c8-0 

00:29:11.360 --> 00:29:14.936
And then if it was felt that the cryobiopsy wasn't enough to make a

fb51e9e1-92a6-4b9c-8a23-7e2466a404c8-1 

00:29:14.936 --> 00:29:17.671
diagnosis, 
they would send them for a surgical lung
fb51e9e1-92a6-4b9c-8a23-7e2466a404c8-2 

00:29:17.671 --> 00:29:18.040
biopsy.
b3fe2d8d-6466-47c3-8c86-d83118f0778c-0 

00:29:19.560 --> 00:29:23.235
And the primary endpoint for the study was a little bit different than what we
b3fe2d8d-6466-47c3-8c86-d83118f0778c-1 

00:29:23.235 --> 00:29:23.840
were used to.
5aff1a30-5147-4e6a-9f98-18ca9c3d4390-0

00:29:23.880 --> 00:29:25.560
So it was chest tube drainage.
41830423-f492-4c11-8a6c-1bd261395760-0

00:29:25.560 --> 00:29:31.440
So that was defined as any requirement for chest tube in the step up group.
d5f3a7bd-65b2-4bd7-8118-7d58f5f9bf80-0 

00:29:31.440 --> 00:29:35.383
So the group that went straight for cryo followed by surgical lung biopsy only if
d5f3a7bd-65b2-4bd7-8118-7d58f5f9bf80-1 

00:29:35.383 --> 00:29:35.720
needed.
05dd3eb1-37ab-470c-b069-843867eb93d2-0

00:29:36.560 --> 00:29:41.790
And then the primary endpoint was met if patients in the surgical lung biopsy
05dd3eb1-37ab-470c-b069-843867eb93d2-1

00:29:41.790 --> 00:29:45.680
group group required a chest tube for more than 24 hours.
fb5068eb-c47b-41d1-b1bd-cb4f0beaa85d-0 

00:29:45.680 --> 00:29:51.767
And they decided on this outcome like in consultation with their REB and with
fb5068eb-c47b-41d1-b1bd-cb4f0beaa85d-1 

00:29:51.767 --> 00:29:53.640
patient representatives.
b99a36e7-4615-4198-b0ba-2316dcdcafc5-0 

00:29:53.640 --> 00:29:57.040
So this was felt to be like an important outcome for patients.
238949e0-e64b-438e-bdbf-ac7af6ff4ff3-0 

00:29:57.600 --> 00:30:00.641
And then secondarily,
they looked at diagnostic yield,
238949e0-e64b-438e-bdbf-ac7af6ff4ff3-1 

00:30:00.641 --> 00:30:03.240
hospital stay, pain and serious adverse events.
07f80b1f-4efb-46e7-b6bf-fb9ff7465009-0 

00:30:04.200 --> 00:30:07.016
So you know,
in terms of their primary outcome,
07f80b1f-4efb-46e7-b6bf-fb9ff7465009-1 

00:30:07.016 --> 00:30:11.183
they did find that, you know,
not surprisingly it was less in the step
07f80b1f-4efb-46e7-b6bf-fb9ff7465009-2 

00:30:11.183 --> 00:30:14.000
up group versus the surgical lung biopsy group.
125fcb8f-50a6-4daa-afa5-9109a24be068-0 

00:30:14.000 --> 00:30:18.628
So almost half of patients in the
surgical lung biopsy group needed a chest
125fcb8f-50a6-4daa-afa5-9109a24be068-1 

00:30:18.628 --> 00:30:23.500
tube for more than 24 hours and versus 11% in the step up group in terms of you
125fcb8f-50a6-4daa-afa5-9109a24be068-2 

00:30:23.500 --> 00:30:27.520
know outcomes that you know we typically are quite interested in.
4f836172-e881-420d-b20e-04a3ed0801bf-0

00:30:27.520 --> 00:30:29.160
So diagnostic yield.
bc0f25ba-9757-4f64-b920-af52844d89f5-0 

00:30:29.160 --> 00:30:34.440
So in the step up group after the cryobiopsy alone it was 82%.
2edec1ee-5b98-41c0-9957-59d88cd30b48-0 

00:30:34.760 --> 00:30:39.734
It did increase to 89% when the subsequent surgical lung biopsy was
2edec1ee-5b98-41c0-9957-59d88cd30b48-1 

00:30:39.734 --> 00:30:45.293
performed after an inclusive trans bronchial cryobiopsy versus 88% for the
2edec1ee-5b98-41c0-9957-59d88cd30b48-2 

00:30:45.293 --> 00:30:47.999
immediate surgical lung biopsy group.
a43c015d-ae40-4383-a12a-41d934dc0226-0 

00:30:48.000 --> 00:30:51.750
So you know,
fairly similar and then hospital length
a43c015d-ae40-4383-a12a-41d934dc0226-1 

00:30:51.750 --> 00:30:57.695
this day was one day in the step up group versus 5 days in the surgical lung biopsy
a43c015d-ae40-4383-a12a-41d934dc0226-2 

00:30:57.695 --> 00:30:58.120
group.
1b7a5786-4343-433e-96c3-6d0f1923332a-0

00:30:58.680 --> 00:31:02.640
And then there was only one serious adverse event in the step up group versus
1b7a5786-4343-433e-96c3-6d0f1923332a-1

00:31:02.640 --> 00:31:05.280
12 in the the immediate surgical lung biopsy group.
9525db12-3de4-4a97-a6ed-66de06d6667e-0 

00:31:05.280 --> 00:31:10.840
So you know, small study,
but you know some more data.
1f30e0ab-b673-4336-a2de-01ef3dd5acf4-0 

00:31:13.720 --> 00:31:16.960
All right,
so when to consider cryobiopsy?
54f0c608-24dd-401e-a620-e03381bca9d8-0

00:31:16.960 --> 00:31:18.320
So what do the guidelines say?
7cc20c5d-b998-4183-a480-bd288514b2a5-0

00:31:18.760 --> 00:31:24.055
So the guidelines tell us if you have a patient with newly identified ILD and the
7cc20c5d-b998-4183-a480-bd288514b2a5-1

00:31:24.055 --> 00:31:26.962
differential diagnosis includes fibrotic HP,
7cc20c5d-b998-4183-a480-bd288514b2a5-2

00:31:26.962 --> 00:31:31.160
the guideline committee suggests transbronchial and cryobiopsy.
63fcf540-362e-4b74-811d-9bbdd7e2e9ba-0 

00:31:35.560 --> 00:31:39.543
In terms of IPF,
the most recent diagnostic guidelines
63fcf540-362e-4b74-811d-9bbdd7e2e9ba-1 

00:31:39.543 --> 00:31:45.192
basically suggest that trans bronchial lung cryobiopsy can be regarded as an
63fcf540-362e-4b74-811d-9bbdd7e2e9ba-2 

00:31:45.192 --> 00:31:50.769
acceptable alternative to surgical lung biopsy when you need histopathology,
63fcf540-362e-4b74-811d-9bbdd7e2e9ba-3 

00:31:50.769 --> 00:31:55.766
assuming that you have, you know, ascent access to a center with the
63fcf540-362e-4b74-811d-9bbdd7e2e9ba-4 

00:31:55.766 --> 00:31:57.360
appropriate expertise.
7a920202-5092-429b-96b9-d2fcd1e7fa87-0

00:31:57.720 --> 00:32:02.261
So there's a conditional recommendation, low quality evidence like a lot of our
7a920202-5092-429b-96b9-d2fcd1e7fa87-1

00:32:02.261 --> 00:32:03.000
stuff in ILD.
aae3a8ad-b141-4588-9f83-57562857037f-0 

00:32:03.120 --> 00:32:07.205
But basically the guideline said, yes, if you're thinking about surgical lung
aae3a8ad-b141-4588-9f83-57562857037f-1 

00:32:07.205 --> 00:32:09.719
biopsy,
you can also think about transbronchial
aae3a8ad-b141-4588-9f83-57562857037f-2 

00:32:09.719 --> 00:32:10.400
lung cryopsy.
75092b7f-5d25-433e-be63-524b6d4da1a8-0

00:32:12.680 --> 00:32:14.680
So what do I do?
627bb79e-9c9d-4100-8d59-212518291829-0

00:32:14.800 --> 00:32:16.360
Again, pragmatically?
aeefeb84-4377-4578-8dce-e1fde4926ffb-0 

00:32:16.360 --> 00:32:21.880
So I do consider cryobiopsy for cases if I am considering a surgical lung biopsy.
a6c92873-fbf3-4f1d-9172-f1eb23db1ddc-0 

00:32:21.880 --> 00:32:25.274
Again, you know,
we're fortunate to discuss these cases at
a6c92873-fbf3-4f1d-9172-f1eb23db1ddc-1 

00:32:25.274 --> 00:32:28.151
an MDD,
certainly important as always to consider
a6c92873-fbf3-4f1d-9172-f1eb23db1ddc-2 

00:32:28.151 --> 00:32:30.279
the safety profile, center expertise.
c1698b66-d89e-4530-9bdf-78ed1d68b12a-0 

00:32:30.280 --> 00:32:33.730
In terms of safety profile,
I would say that we are a bit more
c1698b66-d89e-4530-9bdf-78ed1d68b12a-1 

00:32:33.730 --> 00:32:38.056
aggressive with you know quote-on-quote sending sicker patients for cryobiopsy
c1698b66-d89e-4530-9bdf-78ed1d68b12a-2 

00:32:38.056 --> 00:32:39.480
then surgical lung biopsy.
4d1ed880-cecf-4f9b-865f-036e60279c8c-0 

00:32:39.480 --> 00:32:42.210
We feel that the safety profile is likely a bit,
4d1ed880-cecf-4f9b-865f-036e60279c8c-1 

00:32:42.210 --> 00:32:45.720
you know better for cryobiopsy then then surgical lung biopsy.
cdbd84e9-f234-40c7-9656-d21775276354-0 

00:32:46.120 --> 00:32:49.180
And then as I mentioned before, we do look at disease distribution,
cdbd84e9-f234-40c7-9656-d21775276354-1 

00:32:49.180 --> 00:32:50.440
some more central disease.
050426bd-33b1-4b51-bff6-45695deb7327-0

00:32:50.720 --> 00:32:54.008
I feel better about trying cryobiopsy and always I ask myself,050426bd-33b1-4b51-bff6-45695deb7327-1

00:32:54.008 --> 00:32:56.200
is this result going to change management?
8a7c4eed-5e40-42e2-8ad4-149ed4313438-0

00:32:56.200 --> 00:32:57.880
Because if it's not, then I don't bother.
8299f81b-9277-4feb-a589-3749662216b9-0

00:33:01.280 --> 00:33:04.771
All right,
so let's move on to some of the newish or
8299f81b-9277-4feb-a589-3749662216b9-1

00:33:04.771 --> 00:33:07.868
you know,
what I consider not widely available
8299f81b-9277-4feb-a589-3749662216b9-2

00:33:07.868 --> 00:33:09.120
diagnostic testing.
c2b0890a-c8b4-4554-bb74-93f95f8cb0e7-0 

00:33:09.120 --> 00:33:12.448
So briefly,
I wanted to mention the genomic
c2b0890a-c8b4-4554-bb74-93f95f8cb0e7-1 

00:33:12.448 --> 00:33:13.280
classifier.
bcceb2ff-cf74-42a3-818d-1e5657d51bb4-0 

00:33:13.280 --> 00:33:17.938
So we all know the addition of histopathologic data increases the
bcceb2ff-cf74-42a3-818d-1e5657d51bb4-1 

00:33:17.938 --> 00:33:21.680
confidence of our clinical radiologic ILD
diagnosis.
2bfe945e-2ec7-45cf-83d1-0aef7ce40090-0 

00:33:23.040 --> 00:33:26.129
Unfortunately,
many patients can't or won't undergo a
2bfe945e-2ec7-45cf-83d1-0aef7ce40090-1 

00:33:26.129 --> 00:33:29.962
surgical lung biopsy and we might be left with unclassifiable ILD,
2bfe945e-2ec7-45cf-83d1-0aef7ce40090-2 

00:33:29.962 --> 00:33:32.880
which is up to 25% of patients in certain cohorts.
e7ff125c-ee05-4552-ae11-5ad8d8ae7a79-0 

00:33:33.600 --> 00:33:38.682
And this Envisia genomic classifier was developed using machine learning and RNA
e7ff125c-ee05-4552-ae11-5ad8d8ae7a79-1 

00:33:38.682 --> 00:33:43.011
sequencing on surgical lung biopsy specimens to identify a molecular
e7ff125c-ee05-4552-ae11-5ad8d8ae7a79-2 

00:33:43.011 --> 00:33:45.960
signature that can predict UIP histopathology.
75e1654a-15da-497d-84cf-a9224bb26f92-0

00:33:45.960 --> 00:33:51.216
So they developed this molecular signature using AI essentially and then
75e1654a-15da-497d-84cf-a9224bb26f92-1

00:33:51.216 --> 00:33:56.688
subsequently tested and validated it on transbronchial biopsy specimens to
75e1654a-15da-497d-84cf-a9224bb26f92-2

00:33:56.688 --> 00:33:58.200
identify UIP pattern.
14ab9b5d-3d25-480a-b57d-6c9c41828c65-0

00:33:58.200 --> 00:34:01.560
It can also be done on cryobiopsy specimens too.
faa53930-d53e-4b44-a2c2-9894fafeae47-0 

00:34:03.480 --> 00:34:09.335
And so really what it does is it tells 
you it's a UIP pattern or a non UIP
faa53930-d53e-4b44-a2c2-9894fafeae47-1 

00:34:09.335 --> 00:34:09.960
pattern.
56735518-80e8-4c7f-b7d8-8db94b6a386d-0

00:34:10.040 --> 00:34:15.601
And you know, with this,
all this data showed it had a sensitivity
56735518-80e8-4c7f-b7d8-8db94b6a386d-1

00:34:15.601 --> 00:34:21.909
of 68% and a specificity of 92% for identifying the UIP pattern with
56735518-80e8-4c7f-b7d8-8db94b6a386d-2

00:34:21.909 --> 00:34:24.400
moderate diagnostic agreement.
0bc6a8c7-f1f3-4cd4-9d87-df0eda2a031f-0 

00:34:24.400 --> 00:34:27.476
When you compare the results to the reference standards,
0bc6a8c7-f1f3-4cd4-9d87-df0eda2a031f-1 

00:34:27.476 --> 00:34:29.960
which were either MDD or just histopathology.
3c5f2a82-38ff-4424-8d82-5a678cb39a0d-0

00:34:31.720 --> 00:34:37.280
And there is some data to show improved diagnostic confidence when you integrate
3c5f2a82-38ff-4424-8d82-5a678cb39a0d-1

00:34:37.280 --> 00:34:41.192
A genomic classifier into MDD review, although you know,
3c5f2a82-38ff-4424-8d82-5a678cb39a0d-2

00:34:41.192 --> 00:34:46.135
it's really seems to be better with a probable UIP pattern than than an
3c5f2a82-38ff-4424-8d82-5a678cb39a0d-3

00:34:46.135 --> 00:34:47.920
indeterminate UIP pattern.
06378f64-a01b-4e13-8cf6-927621b4b2fb-0

00:34:47.920 --> 00:34:50.617
So you know,
I think it makes people feel more 
06378f64-a01b-4e13-8cf6-927621b4b2fb-1

00:34:50.617 --> 00:34:55.267
confident about the IPF diagnosis when they get a piece of paper that tells them
06378f64-a01b-4e13-8cf6-927621b4b2fb-2

00:34:55.267 --> 00:34:56.760
that the pattern was UIP.
1bef2d0a-c7ac-4507-8efe-e57135a6d606-0 

00:35:02.160 --> 00:35:02.680
All right.
d8628def-7639-49a4-ac37-96b5b19adede-0 

00:35:02.840 --> 00:35:04.160
So what did the guidelines say?
33de038c-2892-48cc-b387-ac188d209ba0-0

00:35:04.160 --> 00:35:09.757
So the guidelines make no recommendation for or against using the genomic
33de038c-2892-48cc-b387-ac188d209ba0-1

00:35:09.757 --> 00:35:13.765
classifier,
basically because there was insufficient
33de038c-2892-48cc-b387-ac188d209ba0-2

00:35:13.765 --> 00:35:16.640
agreement among the committee members.
06f59c45-b380-425b-b914-7c416ef58895-0

00:35:16.840 --> 00:35:21.400
So I think there was a lot of differences of opinions there.
f26bc28a-a197-4311-b8e4-56e494cd23fa-0 

00:35:22.440 --> 00:35:23.120
So what do I do?
13d4cc58-2a03-4986-b6c8-1d7a981006cd-0

00:35:23.120 --> 00:35:24.520
So I've never ordered one.
4b7e3f77-fc46-4963-9e38-037d61964640-0

00:35:24.520 --> 00:35:28.556
It's expensive, it's not funded, and I'm not sure really it would
4b7e3f77-fc46-4963-9e38-037d61964640-1

00:35:28.556 --> 00:35:30.880
meaningfully change management for me. 7cb866a3-2344-4b84-b07e-49bbe1d272df-0 

00:35:31.440 --> 00:35:35.152
Although, you know,
I'm very curious when we get into the
7cb866a3-2344-4b84-b07e-49bbe1d272df-1 

00:35:35.152 --> 00:35:40.208
discussion portion of the talk to hear what others in the audience think about
7cb866a3-2344-4b84-b07e-49bbe1d272df-2 

00:35:40.208 --> 00:35:41.680
the genomic classifier.
670ed98b-f37a-4b8d-9138-2dbbbdf1d489-0 

00:35:44.480 --> 00:35:46.160
All right,
so let's move on to another case.
53ead6fc-3659-4508-90c0-e7c31e804905-0

00:35:46.160 --> 00:35:51.305
So this was a 45 year old male who had been diagnosed with myelodysplasia and
53ead6fc-3659-4508-90c0-e7c31e804905-1

00:35:51.305 --> 00:35:53.680
had a family history of early greying.
e100c3d6-4aac-41e1-a848-57e1ca31b4d8-0 

00:35:55.040 --> 00:35:59.443
He was undergoing a work up for bone marrow transplant and then was found to
e100c3d6-4aac-41e1-a848-57e1ca31b4d8-1 

00:35:59.443 --> 00:36:01.560
have evidence of ILD on his CT chest.
aa48dfa4-867e-473c-b077-04fe69d4a6ce-0 

00:36:02.040 --> 00:36:11.148
So you can see here just a axial shot of
his CT showing clear evidence of ILD and
aa48dfa4-867e-473c-b077-04fe69d4a6ce-1 

00:36:11.148 --> 00:36:17.480
we sent him for telomere testing and this is the result.
1760f51c-9bd5-436c-b018-3efc3957b2cc-0 

00:36:17.520 --> 00:36:23.744
And so you can see basically each panel here is just showing different lymphoid
1760f51c-9bd5-436c-b018-3efc3957b2cc-1 

00:36:23.744 --> 00:36:24.600
cell lines. 
28067371-3fc8-4298-bd0d-729b4c58ec89-0

00:36:25.480 --> 00:36:30.345
And the bottom line is the first percentile of telomere length and then
28067371-3fc8-4298-bd0d-729b4c58ec89-1

00:36:30.345 --> 00:36:32.440
the top is the 99th percentile.
37ea6552-7f27-4516-8ee0-692f420e5007-0

00:36:33.440 --> 00:36:37.343
And then you can see that you know, so and then on the side is the actual
37ea6552-7f27-4516-8ee0-692f420e5007-1

00:36:37.343 --> 00:36:39.400
length and then on the bottom is agent.
e2319f22-4d0d-4f32-b70a-ad2d5c1b71db-0 

00:36:39.400 --> 00:36:42.824
So you can see that, you know,
his telomere length is well below the
e2319f22-4d0d-4f32-b70a-ad2d5c1b71db-1 

00:36:42.824 --> 00:36:46.000
first first percentile across all of these lymphoid cell lines.
f57cce2b-23bd-42fe-b3c1-785b1a4c6048-0 

00:36:50.320 --> 00:36:54.280
So when do I consider telomere length or genetic testing?
b661159e-b20a-474b-9572-556b314ea07f-0 

00:36:54.280 --> 00:36:59.745
So really when there's a strong family history of ILD, young age at onset,
b661159e-b20a-474b-9572-556b314ea07f-1 

00:36:59.745 --> 00:37:03.862
I think about it when there's a history of liver disease,
b661159e-b20a-474b-9572-556b314ea07f-2 

00:37:03.862 --> 00:37:06.559
early greying and hematologic disorders.
290f7eb1-f80f-42b4-868e-7afa16f7d835-0 

00:37:07.040 --> 00:37:08.920
And then I always consider genetics referral.
81c4f4ac-051c-4bc5-b163-a5e05806b270-0

00:37:08.920 --> 00:37:10.400
I usually do these hand in hand.
d9feb31d-0a92-44bf-a3c7-5edf01280fdd-0 

00:37:10.400 --> 00:37:14.240
If I'm going to send for telomere testing, I just send a genetics referral.
081060e6-9cd5-44c7-9025-5de85cd017a5-0

00:37:15.560 --> 00:37:17.911
You know,
I think if you're thinking of short
081060e6-9cd5-44c7-9025-5de85cd017a5-1

00:37:17.911 --> 00:37:20.313
telomeres,
there's other implications that the
081060e6-9cd5-44c7-9025-5de85cd017a5-2

00:37:20.313 --> 00:37:23.840
genetics team is really helpful at thinking about and screening for.
fbe174d1-88c2-4665-95fb-3f035626fabb-0 

00:37:29.890 --> 00:37:30.250
All right.
a5254e49-ba83-4972-be1a-2898ebdc7d9c-0 

00:37:30.250 --> 00:37:34.385
And so, you know,
in the last maybe 5 to 10 minutes of the
a5254e49-ba83-4972-be1a-2898ebdc7d9c-1 

00:37:34.385 --> 00:37:38.591
of the talk here,
I just want to touch on some emerging and
a5254e49-ba83-4972-be1a-2898ebdc7d9c-2 

00:37:38.591 --> 00:37:44.410
future diagnostics for ILD I think it's a super, super interesting and active area.
86b03351-a35f-4969-9e08-65ef6d8f90ad-0

00:37:44.410 --> 00:37:47.574
And you know,
I hope that one day our entire diagnostic
86b03351-a35f-4969-9e08-65ef6d8f90ad-1

00:37:47.574 --> 00:37:50.570
approach to ILD is going to be completely different.
ef064579-c414-4815-bd26-7243b2eaad51-0 

00:37:52.520 --> 00:37:56.640
And so yes, there are lots,
some and some further along than others.
5a77b857-95e1-4cf0-b408-b9047acb2d32-0

00:37:56.640 --> 00:38:02.880
So I think probably many of you are familiar with peripheral blood biomarkers
5a77b857-95e1-4cf0-b408-b9047acb2d32-1

00:38:02.880 --> 00:38:08.880
like MMP 7 and SPD, for example,
that you know are found to be elevated in
5a77b857-95e1-4cf0-b408-b9047acb2d32-2

00:38:08.880 --> 00:38:10.400
patients with ILDs.
c1c481da-46d2-4ede-8800-f781e8f500dc-0 

00:38:10.520 --> 00:38:14.190
And, you know,
some are associated with specific ILDs
c1c481da-46d2-4ede-8800-f781e8f500dc-1 

00:38:14.190 --> 00:38:18.200
and certainly associated with, you know, more progression.
48d45ad2-5a0e-4706-84e1-beabede8ba31-0 

00:38:18.880 --> 00:38:22.371
And so I think that this is a really, you know, important and again,
48d45ad2-5a0e-4706-84e1-beabede8ba31-1 

00:38:22.371 --> 00:38:23.080
evolving area.
e18b83f9-b2f7-4d62-8219-a99d7be41a8c-0 

00:38:23.080 --> 00:38:26.734
There's a bunch of other, you know, biomarkers that are, you know,
e18b83f9-b2f7-4d62-8219-a99d7be41a8c-1 

00:38:26.734 --> 00:38:28.480
being tested and, and validated.
3f89d05d-4607-49e7-9086-03ec46b7017b-0

00:38:30.200 --> 00:38:35.482
There's also a lot of novel molecular diagnostic techniques that are under
3f89d05d-4607-49e7-9086-03ec46b7017b-1

00:38:35.482 --> 00:38:39.145
investigations,
including proteomic and metabolomic 
3f89d05d-4607-49e7-9086-03ec46b7017b-2

00:38:39.145 --> 00:38:43.160
analysis of blood BAL specimens and lung tissue samples.
86140229-6dbb-4467-bb36-b96e0033dc79-0

00:38:43.800 --> 00:38:47.005
There's also research looking at liquid biopsy,
86140229-6dbb-4467-bb36-b96e0033dc79-1

00:38:47.005 --> 00:38:51.080
so analysis of cell free circulating DNA fragments in blood.
8084178e-1156-47b1-a3c1-7c90363c672f-0

00:38:52.320 --> 00:38:56.101
They're also using this in oncology certainly, you know,
8084178e-1156-47b1-a3c1-7c90363c672f-1

00:38:56.101 --> 00:39:01.143
computer based algorithmic analysis of radiology and histopathology and ILD
8084178e-1156-47b1-a3c1-7c90363c672f-2

00:39:01.143 --> 00:39:03.200
using deep learning techniques.
504863c1-2c95-448c-beb3-f17a37fea74c-0 

00:39:04.120 --> 00:39:08.462
You know, one of our,
one of the issues with ILD diagnostics is
504863c1-2c95-448c-beb3-f17a37fea74c-1 

00:39:08.462 --> 00:39:13.415
particularly with radiology and histopathology is there's a lot of inter
504863c1-2c95-448c-beb3-f17a37fea74c-2 

00:39:13.415 --> 00:39:14.840
observer variability.
0debb382-b3aa-4e40-887e-8b668fc39ab5-0 

00:39:15.400 --> 00:39:20.030
And so, you know, the idea is, you know, maybe we can use AI to to help address
0debb382-b3aa-4e40-887e-8b668fc39ab5-1 

00:39:20.030 --> 00:39:20.320
that.
c5709b7e-8659-404b-a688-fe42a07fd31c-0

00:39:21.240 --> 00:39:25.384
And then I wanted to spend just a little bit of time talking about endobronchial
c5709b7e-8659-404b-a688-fe42a07fd31c-1 

00:39:25.384 --> 00:39:29.120
optical coherence tomography or EBOCT, because I think it's really cool.
0fe6af9a-3d2f-4b9d-b5ae-2bdeef7e4c5e-0 

00:39:30.400 --> 00:39:34.563
It's a non invasive non-ionizing radiation technology which uses low
0fe6af9a-3d2f-4b9d-b5ae-2bdeef7e4c5e-1 

00:39:34.563 --> 00:39:39.572
coherence light waves to generate really high resolution images of soft tissues to
0fe6af9a-3d2f-4b9d-b5ae-2bdeef7e4c5e-2 

00:39:39.572 --> 00:39:40.839
less than 10 microns.
ca14dcfe-933c-494c-8b27-035fbec4c83b-0 

00:39:41.240 --> 00:39:45.643
And it can assess features like subplural fibrosis, architectural distortion,
ca14dcfe-933c-494c-8b27-035fbec4c83b-1 

00:39:45.643 --> 00:39:48.579
microscopic honeycombing, airway centered fibrosis,
ca14dcfe-933c-494c-8b27-035fbec4c83b-2 

00:39:48.579 --> 00:39:51.119
all without having to undergo a lung biopsy.
dceb7d1e-b639-46c7-ac09-56a144e85f0d-0 

00:39:51.120 --> 00:39:56.399
And so preliminary studies suggest that EBOCT has high sensitivity and
dceb7d1e-b639-46c7-ac09-56a144e85f0d-1 

00:39:56.399 --> 00:40:02.570
specificity for identifying UIP and also for differentiating between different ILD
dceb7d1e-b639-46c7-ac09-56a144e85f0d-2 

00:40:02.570 --> 00:40:03.240
subtypes.
184841a1-d0f5-43b2-a651-322f241633fa-0

00:40:06.040 --> 00:40:11.960
And so here's just a figure showing you what EBOCT looks like.
e2882df8-5220-4110-a0d5-335577825def-0 

00:40:12.080 --> 00:40:18.640
So here panel A is like a volumetric EBOCT image.
23347660-5a05-4e78-bbb8-db1b1bf10e94-0

00:40:18.640 --> 00:40:20.880
And so, you know, basically you would just.
5479b3c1-c5d8-4d55-8358-f4d15b473798-0

00:40:21.360 --> 00:40:28.553
Do this via bronchoscopy and, you know, collect these images and then, you know,
5479b3c1-c5d8-4d55-8358-f4d15b473798-1

00:40:28.553 --> 00:40:33.970
somebody trained in,
in looking at them would interpret them
5479b3c1-c5d8-4d55-8358-f4d15b473798-2

00:40:33.970 --> 00:40:36.280
and, and you can see that.
a1482812-ccd8-4ed7-bead-6327ccf8e067-0 

00:40:36.520 --> 00:40:41.031
So panels B and
C are basically just cross-sectional
a1482812-ccd8-4ed7-bead-6327ccf8e067-1 

00:40:41.031 --> 00:40:45.960
images from from panel A and the little A here is alveoli.
99b2490e-14d6-4fe1-a4c5-511f3c7ab64c-0 

00:40:45.960 --> 00:40:50.067
So,
and then AW is is airways and these ones,
99b2490e-14d6-4fe1-a4c5-511f3c7ab64c-1 

00:40:50.067 --> 00:40:53.640
this, this example has minimal fibrosis.
e70e5c1c-e3af-4241-8f8c-f962f2c274b0-0 

00:40:53.640 --> 00:40:56.360
This is, you know,
mostly kind of normal lung parenchyma.
bf455626-5058-449b-918c-9f3dcf075a8e-0 

00:40:56.360 --> 00:41:02.320
This is corresponding lung tissue in
patients who also underwent a lung biopsy.
1d8c9dee-9442-44ce-b661-7835cb7baae5-0 

00:41:07.000 --> 00:41:12.280
And so this was the article from which the figure came.
f39f53f0-2020-4124-a6f2-f2146661f860-0 

00:41:12.280 --> 00:41:16.400
It's really interesting study from Lita Hariri's group.
0ccdc2c3-a447-4078-957e-a16c609efb8c-0 

00:41:16.440 --> 00:41:21.208
And so it was a prospective study comparing EBOCT to surgical lung biopsy
0ccdc2c3-a447-4078-957e-a16c609efb8c-1 

00:41:21.208 --> 00:41:25.720
in 27 patients who had unclassifiable or low confidence fibrotic ILD.
0f9e75eb-912b-496a-adf9-ad3532411016-0

00:41:26.800 --> 00:41:30.174
And they, I mean,
there's a small number of patients,
0f9e75eb-912b-496a-adf9-ad3532411016-1

00:41:30.174 --> 00:41:34.360
but they found that EBOCT had 100% sensitivity and specificity for
0f9e75eb-912b-496a-adf9-ad3532411016-2

00:41:34.360 --> 00:41:39.360
histopathologic diagnosis of UIP and then making the clinical diagnosis of IPF.
b7e16f45-a8ec-49bb-a551-93e8dd63a92f-0 

00:41:46.970 --> 00:41:51.150
So you know,
just to kind of shape a vision, you know,
b7e16f45-a8ec-49bb-a551-93e8dd63a92f-1 

00:41:51.150 --> 00:41:52.290
for the future.
ecf6ed3b-af6c-4f76-8034-b22816952340-0 

00:41:52.410 --> 00:41:58.938
My hope is that a lot of these, you know, will basically refine, you know,
ecf6ed3b-af6c-4f76-8034-b22816952340-1 

00:41:58.938 --> 00:42:05.728
our current available ILD diagnostics,
you know, improving safety, obviously,
ecf6ed3b-af6c-4f76-8034-b22816952340-2 

00:42:05.728 --> 00:42:12.517
but incorporate some of these emerging tools like maybe EBOCT can replace the
ecf6ed3b-af6c-4f76-8034-b22816952340-3 

00:42:12.517 --> 00:42:14.519
need for actual tissue.
9fd6065c-629a-456f-9588-bd482a279f02-0

00:42:14.520 --> 00:42:19.294
And, you know,
maybe AI can help with some of our,
9fd6065c-629a-456f-9588-bd482a279f02-1

00:42:19.294 --> 00:42:23.040
you know, issues with CT interpretation.
02061fe4-29e5-4e30-a47b-41f24e413da7-0

00:42:23.920 --> 00:42:28.418
And then, you know, these blood samples, biomarkers, genomic markers,
02061fe4-29e5-4e30-a47b-41f24e413da7-1

00:42:28.418 --> 00:42:33.560
molecular signatures can help not only with diagnostics but really phenotyping.
e53e4f01-518f-43d7-8ce8-b939eb2c597b-0 

00:42:33.560 --> 00:42:37.468
So we can, you know,
identify patients who are most likely to
e53e4f01-518f-43d7-8ce8-b939eb2c597b-1 

00:42:37.468 --> 00:42:39.360
respond to certain treatments.
91e47979-8f79-4182-b0a8-e0f4e4ed37fc-0

00:42:39.360 --> 00:42:43.120
For example,
we can help prognosticate patients.
07385650-8b84-4ee0-890b-9127984bdbd5-0

00:42:43.120 --> 00:42:48.170
You know, we always have, we all know that ILD is really highly
07385650-8b84-4ee0-890b-9127984bdbd5-1

00:42:48.170 --> 00:42:50.400
variable in terms of of prognosis.
66a59782-5421-4a3d-b657-e85d6f8c3598-0

00:42:50.400 --> 00:42:54.042
And so really identifying those patients who are at highest risk for progressive
66a59782-5421-4a3d-b657-e85d6f8c3598-1

00:42:54.042 --> 00:42:56.695
disease and you know,
being more aggressive with treatment
66a59782-5421-4a3d-b657-e85d6f8c3598-2

00:42:56.695 --> 00:42:57.640
early on for example.
efc7d472-66e7-4ade-bf3a-2b6c73d5089a-0 

00:42:57.640 --> 00:43:01.120
So you know,
this is a real vision for the future.
fd573848-7438-4329-8c6a-07e63d8d133f-0 

00:43:03.240 --> 00:43:05.640
All right, well,
I'm supposed to leave about 15 minutes for
fd573848-7438-4329-8c6a-07e63d8d133f-1 

00:43:05.640 --> 00:43:06.120
questions.
3e2d2abf-b745-4671-a2e1-414ce3a9c8fa-0 

00:43:06.120 --> 00:43:11.600
So maybe I will wrap it up there with just a quick summary.
53d4f7ca-6187-4915-bbfb-96eb640b3688-0

00:43:11.600 --> 00:43:16.664
So consider BAL transbronchial lung cryobiopsy and surgical lung biopsy in
53d4f7ca-6187-4915-bbfb-96eb640b3688-1

00:43:16.664 --> 00:43:18.960
your undifferentiated ILD patient.
21f28053-222e-4c4f-a908-72ef9c260d2c-0

00:43:18.960 --> 00:43:21.974
Ask yourself,
is it safe? and will it change my
21f28053-222e-4c4f-a908-72ef9c260d2c-1

00:43:21.974 --> 00:43:22.680
management?
28d5d896-768f-4c06-b03d-17d21e063036-0

00:43:23.960 --> 00:43:28.802
Consider genetic testing slash telomere length testing in certain patients and
28d5d896-768f-4c06-b03d-17d21e063036-1

00:43:28.802 --> 00:43:33.400
get excited because there's lots of emerging diagnostics down the pipeline
28d5d896-768f-4c06-b03d-17d21e063036-2

00:43:33.400 --> 00:43:34.319
and stay tuned.
994c7d75-75cb-44f9-9d11-80b7a02074e7-0

00:43:38.120 --> 00:43:39.680
Great, thank you so much.
ab747f49-dd89-4205-9541-b59c642b1c7e-0 

00:43:39.680 --> 00:43:40.840
That was such a great talk.

Learning objectives:

  • Understand the role of advanced diagnostic testing in the evaluation and management of ILD

  • Review the latest advancements in diagnostic techniques for ILD

  • Discuss the benefits and limitations of different diagnostic tests in the context of ILD

Program date: April 30, 2025

Headshot of Dr. Jolene Fisher, MD, FRCPC

Speaker: Dr. Jolene Fisher MD, FRCPC

Respirologist at the University Health Network 
Research Director of the Interstitial Lung Disease Clinic Toronto General Hospital

Headshot of Dr. Stacey Lok MD, FRCPC

Moderator: Dr. Stacey Lok MD, FRCPC

Assistant Professor Respirology, 
Critical Care and Sleep Medicine
University of Saskatchewan

The presenters are solely responsible for developing the content of this presentation and maintaining scientific accuracy, objectivity, and balance. Any discussions of clinical practice or treatment represent the opinions of the presenter alone. This video is made available for attendees, registrants, and individuals requesting further information on this learning program.